rfhg_77216.1

Basic information about the TSS

---

TSS ID: rfhg_77216.1 Species: human Chr: chr6		Start: 2971842 End: 2971849 Strand: -
Source datasets
Protocol
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3805173,EH38E2440258)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AK314578:-35 GeneID: 5269 HGNC/MGI_ID: HGNC:8950 UniProt_ID: Nearer transcript ids and distances:

Gene_name: SERPINB6 Gene_symbol: SERPINB6 Gene_synonyms: CAP PTI Gene_source: HGNC:8950

TATA-Box annotation

---

Distance to TSS:	-278
Nearest PromoterID:	NM_001271822
Entrez ID:	5269
Nearest Unigene:	Hs.519523
Nearest Refseq:	NM_004568
Nearest Ensembl:	ENSG00000124570
Gene Name:	SERPINB6
Gene Alias:	CAP|DFNB91|MSTP057|PI-6|PI6|PTI|SPI3
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.625000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SERPINB6 p2@SERPINB6 p3@SERPINB6 p4@SERPINB6 p5@SERPINB6 p6@SERPINB6 p7@SERPINB6 p8@SERPINB6 p9@SERPINB6 p10@SERPINB6
Sample		p1@SERPINB6	p2@SERPINB6	p3@SERPINB6	p4@SERPINB6	p5@SERPINB6	p6@SERPINB6	p7@SERPINB6	p8@SERPINB6	p9@SERPINB6	p10@SERPINB6
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	6.62	4.09	5.26	2.92	1.17	1.95	0.78	0.19	0.19	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	9.71	5.26	3.44	2.83	1.01	1.62	1.21	1.01	0.20	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	6.75	4.05	3.09	2.31	0.39	1.54	0.96	0.58	0.58	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	4.78	5.41	2.49	1.87	0.83	2.29	1.04	0.83	0.00	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	5.40	5.40	2.25	2.47	0.90	0.67	1.35	0.22	0.00	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	6.40	5.04	2.52	0.97	0.58	1.55	0.39	0.19	0.19	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	7.63	5.45	3.70	3.27	1.96	1.53	1.53	1.31	0.65	0.87
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	8.96	6.54	1.45	1.70	0.24	1.94	0.48	0.48	0.00	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	6.20	3.85	1.71	1.71	1.07	1.71	0.64	0.43	0.64	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	13.33	9.85	0.58	2.32	1.74	1.16	0.58	0.58	1.16	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	6.47	4.04	1.62	1.62	0.81	1.21	2.43	2.02	1.21	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	8.54	8.13	2.03	2.44	0.41	1.63	1.63	1.22	1.22	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	34.01	9.67	8.87	4.51	2.58	2.26	2.42	1.13	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	27.06	7.97	6.77	2.41	3.76	1.95	2.26	1.35	0.45	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	28.76	9.22	7.25	4.17	2.20	2.20	2.42	1.10	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	27.92	8.80	8.80	2.51	3.02	0.75	2.01	1.51	0.25	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	24.24	10.27	5.68	4.59	2.18	2.18	1.09	0.87	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	25.73	7.59	8.44	6.33	1.69	2.53	1.27	1.69	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	20.79	6.40	6.40	3.73	4.27	2.67	2.67	1.07	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	37.61	10.08	9.48	3.91	2.86	1.81	1.20	0.90	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	32.34	8.69	9.22	5.35	2.94	2.41	1.74	1.60	0.00	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	32.45	9.49	7.08	4.66	5.01	2.42	1.73	0.86	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	26.50	11.50	7.24	3.62	2.07	2.46	1.68	0.39	0.90	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	24.51	9.46	8.49	3.88	2.43	1.94	2.18	0.24	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	29.67	8.51	7.74	3.61	2.32	1.81	2.06	0.00	0.26	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	26.27	6.96	8.23	3.80	3.80	0.95	1.27	1.58	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	28.02	13.19	4.95	3.30	2.75	2.75	2.20	0.00	0.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	33.71	7.07	9.67	2.36	3.30	2.59	1.89	1.18	0.47	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	31.17	7.11	8.24	5.01	3.55	1.29	1.29	1.45	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	32.57	8.87	8.51	3.26	2.71	1.45	1.45	1.45	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	29.52	7.33	8.37	4.61	2.30	2.93	1.88	1.26	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	26.77	9.57	10.94	3.71	2.93	1.76	1.76	0.39	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	32.92	8.23	6.75	4.22	1.90	2.74	2.32	0.84	0.42	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	27.71	15.17	9.40	4.62	2.64	2.80	2.80	1.81	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	31.79	7.67	8.60	4.30	2.43	0.75	1.50	1.50	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	28.55	7.86	5.75	5.37	2.11	1.92	3.26	0.57	0.77	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	32.29	5.11	6.54	3.47	2.45	2.86	1.84	1.43	0.82	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	25.19	9.47	7.25	4.03	2.22	2.82	2.42	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	28.09	8.10	7.83	5.13	2.97	3.24	0.54	0.54	0.27	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	28.33	6.48	5.52	4.08	2.64	1.68	2.16	2.40	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	24.94	6.35	5.41	4.23	1.88	2.12	1.18	1.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	25.33	7.91	6.15	3.95	2.93	1.76	1.32	0.59	0.44	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	22.99	7.38	8.01	4.85	2.53	3.37	1.90	1.05	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	25.00	8.39	8.04	4.02	3.67	2.80	1.92	2.45	0.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	29.71	7.83	5.62	2.01	1.41	2.61	1.81	1.61	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	23.26	6.98	7.91	3.26	1.86	2.33	1.86	0.93	0.23	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	21.83	8.40	5.28	3.84	2.16	4.08	2.40	2.40	0.72	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	20.86	7.75	5.07	3.87	4.17	2.09	2.68	0.60	0.89	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	20.35	7.18	8.38	2.39	2.15	2.39	2.63	1.20	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	22.65	6.27	7.08	2.22	1.42	1.62	2.22	2.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	23.77	6.35	5.12	4.51	3.69	1.64	1.84	1.02	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	19.35	6.45	9.56	2.45	1.56	1.78	3.34	1.11	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	55.97	13.99	13.99	0.00	0.00	0.00	0.00	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	16.32	9.23	6.74	5.32	1.42	1.42	3.55	1.77	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	18.23	6.30	3.98	2.98	2.65	1.99	1.66	1.99	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	19.30	19.30	3.36	3.36	3.36	4.19	0.84	0.00	2.52	2.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	17.45	9.64	3.21	2.30	1.38	2.76	0.46	1.38	0.46	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	15.88	4.86	3.89	1.94	1.94	2.27	1.30	1.30	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	19.27	6.74	5.14	4.18	0.96	2.25	2.89	0.96	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	19.80	11.63	5.66	2.83	2.20	1.89	1.57	2.51	0.63	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	14.10	6.35	2.82	1.41	0.71	0.71	0.71	1.41	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	16.26	7.29	3.93	4.49	0.56	1.12	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	18.31	9.55	3.18	2.39	1.59	2.39	0.00	1.59	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	23.10	9.51	5.44	1.36	1.70	2.38	1.70	1.36	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	22.09	4.87	4.22	2.60	1.62	2.27	2.60	0.65	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	21.65	6.39	3.55	1.77	1.42	1.42	1.77	1.77	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	0.00	32.33	0.00	16.16	0.00	16.16	0.00	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	7.90	23.69	7.90	23.69	0.00	7.90	0.00	0.00	15.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	26.33	4.39	6.34	3.90	2.44	2.93	1.46	0.98	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	31.24	6.45	3.47	3.47	0.99	0.50	0.50	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	28.15	6.10	5.63	2.35	2.35	1.88	0.00	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	34.11	7.62	5.30	4.31	2.32	0.66	0.66	2.32	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	31.55	4.02	6.81	5.26	3.09	0.62	1.24	0.93	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	34.24	4.89	6.42	3.97	2.45	0.61	0.61	0.61	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	10.29	11.25	5.23	5.07	1.43	2.85	4.43	2.85	0.79	0.00
Adipocyte - breast, donor2	11327-117E4	11.39	32.09	5.61	3.85	2.25	3.53	5.29	1.93	0.64	0.16
Adipocyte - omental, donor1	11473-119C6	13.10	12.98	4.58	6.74	3.44	2.93	3.44	2.04	0.89	0.13
Adipocyte - omental, donor2	11474-119C7	16.44	10.46	5.23	2.99	1.49	1.49	0.00	1.49	0.00	1.49
Adipocyte - omental, donor3	11475-119C8	15.74	16.08	4.69	6.03	1.00	0.67	1.34	3.35	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	11.48	9.57	7.02	7.66	1.28	3.19	0.64	0.64	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	13.19	19.79	7.70	4.40	0.00	5.50	1.10	2.20	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	19.42	11.29	3.16	3.61	2.71	1.35	2.26	1.35	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	26.07	11.30	5.39	2.95	1.91	2.43	2.09	1.39	0.00	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	16.43	5.08	5.48	2.93	0.78	0.59	0.78	1.37	0.20	0.59
Adipocyte differentiation, day04, donor2	13022-139D7	19.82	4.12	2.06	1.54	1.03	1.80	0.00	0.51	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	20.07	6.97	3.07	2.51	1.67	0.84	0.56	1.12	0.84	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	20.57	5.29	5.29	4.11	2.35	2.94	1.18	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	15.52	16.89	4.34	3.86	2.09	3.30	2.49	2.57	1.13	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	16.78	3.87	2.90	2.90	1.29	1.29	0.97	1.29	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	12.26	5.33	4.80	1.60	1.07	1.60	0.53	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	20.59	5.01	6.12	3.34	0.56	0.00	0.00	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	21.21	24.12	8.73	4.99	2.08	4.99	4.57	3.33	2.08	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	16.07	10.30	3.52	1.76	3.01	2.01	1.00	1.51	0.00	0.75
Adipocyte differentiation, day12, donor3	13027-139E3	18.65	14.07	6.54	3.60	1.31	3.27	1.31	2.29	0.00	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	15.22	15.53	4.57	1.83	2.74	3.04	3.04	1.83	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	28.29	30.94	6.63	6.63	3.09	2.43	4.86	2.21	0.66	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	10.40	2.87	2.87	1.43	0.72	0.36	0.72	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	11.98	5.99	11.98	3.59	0.00	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	13.31	5.94	9.18	3.42	1.26	0.18	0.00	0.18	0.72	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	11.71	1.67	18.41	6.69	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	14.18	9.04	19.11	4.73	2.47	0.62	1.03	0.62	0.41	0.00
Anulus Pulposus Cell, donor1	11248-116E6	37.87	14.76	10.30	4.12	3.89	2.29	2.98	2.06	0.69	0.00
Anulus Pulposus Cell, donor2	11463-119B5	22.04	6.12	7.59	2.94	2.69	1.96	1.71	1.47	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	11.68	17.97	8.99	4.49	3.59	1.80	2.25	1.80	0.90	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	12.59	11.29	7.81	4.78	1.30	3.47	1.30	3.47	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	10.70	14.98	10.70	0.00	0.00	4.28	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.85	15.84	6.88	5.38	2.99	3.59	2.69	1.20	0.60	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	12.65	13.91	6.32	2.53	1.26	6.32	2.53	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	13.20	15.18	10.56	1.98	2.64	3.96	1.98	4.62	0.66	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.02	9.10	8.45	4.87	2.60	3.25	0.97	0.65	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	14.08	12.14	7.77	5.34	0.97	4.85	0.97	2.43	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	14.25	12.47	4.75	5.94	2.97	6.53	1.19	2.38	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	15.44	12.43	6.40	3.77	2.26	3.01	1.13	0.38	0.75	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	11.61	15.24	7.98	5.81	1.45	3.63	2.18	2.18	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	11.28	8.78	3.76	6.27	1.25	0.00	2.51	1.25	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	14.66	14.00	5.77	5.44	3.29	1.32	2.47	1.32	0.66	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	16.38	13.65	8.19	8.19	0.00	2.73	0.00	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	15.53	13.12	5.43	5.28	2.11	3.02	1.36	1.51	0.45	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	19.29	14.47	6.97	5.36	3.21	3.21	1.61	2.68	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	11.15	10.96	6.99	4.16	3.21	1.70	2.83	1.32	0.57	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	12.03	11.76	5.88	4.54	2.14	2.14	3.21	1.07	0.27	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	19.51	16.58	3.90	3.90	2.93	0.98	2.93	3.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	11.11	9.95	8.46	4.81	2.82	1.66	1.49	2.32	0.33	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	6.00	8.41	7.20	7.20	1.20	2.40	1.20	1.20	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	14.16	3.54	10.62	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	9.61	11.66	6.86	7.03	2.40	2.57	2.23	0.69	1.03	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	12.58	4.19	8.39	0.00	12.58	4.19	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	10.19	14.08	9.22	4.85	2.91	2.91	0.97	2.91	1.94	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	11.76	11.76	6.83	6.07	2.66	2.28	3.04	0.76	1.14	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	14.54	18.17	3.63	3.63	0.00	0.00	0.00	1.21	2.42	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	15.39	17.10	9.69	6.27	0.57	3.99	1.14	2.85	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	14.32	12.19	4.92	6.84	1.92	2.78	1.71	1.92	0.64	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	13.42	13.68	5.42	6.97	2.32	2.06	1.29	2.06	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.61	15.01	6.10	6.10	1.41	2.82	1.88	0.94	0.47	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	16.40	12.22	6.43	5.14	0.96	3.22	2.57	1.61	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	11.42	9.99	7.13	4.28	2.85	2.14	1.43	1.43	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.77	14.04	5.26	5.85	2.92	2.92	1.17	1.75	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	13.85	13.25	6.62	6.32	2.11	3.01	0.60	0.90	0.60	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	11.88	15.44	9.50	3.56	2.38	2.38	2.38	2.38	1.19	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	11.19	16.78	7.12	5.59	4.07	2.03	2.54	2.03	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	12.73	13.75	8.66	4.33	2.55	1.78	3.57	1.78	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	9.53	9.53	8.90	7.62	2.54	2.54	1.27	2.54	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	9.06	9.06	6.47	6.90	2.59	3.02	0.43	0.86	0.86	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.85	9.53	6.56	7.83	3.18	2.75	1.48	1.48	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	11.02	12.47	6.09	5.51	2.32	2.90	1.45	2.61	0.58	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	13.23	5.67	6.61	3.78	2.83	1.89	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.22	13.73	7.12	5.93	1.02	2.54	1.53	1.70	0.34	0.17
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	23.16	11.58	6.95	4.63	0.00	2.32	0.00	6.95	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	12.68	23.24	8.45	0.00	0.00	2.11	0.00	0.00	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	10.94	12.01	6.43	3.86	2.36	1.72	1.29	1.07	0.43	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	7.22	16.85	6.02	7.82	0.60	3.01	1.80	2.41	0.60	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	11.66	17.50	4.37	5.10	2.92	3.64	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	12.64	12.87	7.13	3.91	1.61	0.69	1.61	2.07	0.92	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	12.75	10.20	5.10	5.10	5.10	0.00	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	15.00	12.71	5.85	5.08	3.05	1.78	1.27	2.29	1.02	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	14.86	13.21	8.88	4.34	2.27	1.24	1.03	3.10	0.41	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	10.40	10.71	7.65	3.98	1.53	3.37	1.84	0.31	0.31	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	10.99	14.82	9.08	3.35	2.87	5.26	2.39	1.43	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	10.42	9.31	7.10	4.21	1.55	1.33	2.22	2.22	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	12.21	12.21	6.10	7.63	4.58	4.58	1.53	3.05	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	9.97	12.74	5.54	4.43	2.22	3.32	2.77	1.66	0.55	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	8.74	12.18	6.09	5.03	1.85	2.12	1.32	2.38	0.53	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	12.36	10.18	8.00	3.63	0.36	0.73	1.82	2.54	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	28.12	26.77	8.35	7.37	3.68	6.26	3.56	2.33	1.72	0.00
Astrocyte - cerebellum, donor2	11580-120F5	24.65	7.87	9.76	4.11	2.57	3.08	2.23	0.51	0.86	0.00
Astrocyte - cerebellum, donor3	11661-122F5	8.60	8.81	15.52	4.19	2.94	3.78	4.19	2.10	0.42	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	27.89	56.12	12.55	15.34	12.20	6.62	11.85	3.14	1.74	1.05
Astrocyte - cerebral cortex, donor2	11316-117D2	24.43	27.50	11.49	9.54	4.69	6.63	7.60	3.07	1.94	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	29.38	34.01	11.78	12.53	7.76	7.01	8.95	4.62	2.54	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor1	12241-129G9	33.21	4.71	2.88	2.09	3.14	0.52	0.52	0.78	0.00	0.52
Basophils, donor2	12242-129H1	35.72	6.49	3.61	1.44	2.16	0.00	0.00	0.36	2.16	0.36
Basophils, donor3	12243-129H2	28.37	3.82	4.26	1.18	1.76	0.29	0.15	0.29	0.15	1.47
Bronchial Epithelial Cell, donor1	11511-119G8	12.07	9.92	4.96	4.10	1.72	0.43	0.43	0.86	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	7.77	2.29	8.69	2.29	0.46	0.46	0.00	0.46	0.46	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	0.00	21.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	21.34	16.95	6.28	5.02	3.77	0.63	0.00	0.63	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	14.35	9.15	3.54	4.16	1.46	0.42	0.00	0.21	0.42	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	19.11	10.13	8.52	2.76	2.99	0.46	0.92	0.00	0.23	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	7.20	4.86	8.28	3.24	1.98	0.36	0.18	0.18	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	4.19	0.70	1.16	0.23	0.23	0.00	0.00	0.00	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	88.90	16.95	5.76	5.44	7.35	2.56	0.96	2.56	0.96	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	93.08	20.68	20.68	31.03	0.00	20.68	0.00	10.34	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	58.61	5.64	2.25	5.07	5.07	2.25	1.13	1.13	0.56	3.38
CD14+ Monocytes, donor2	11305-117B9	38.79	6.12	2.04	1.67	1.30	0.74	0.37	0.19	0.56	2.04
CD14+ Monocytes, donor3	11381-118B4	44.13	7.90	3.73	1.76	4.17	1.32	0.00	0.66	0.88	1.32
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	54.34	12.17	10.19	7.08	7.64	1.13	0.57	1.13	0.00	3.11
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	56.86	21.99	7.58	5.31	4.93	1.52	0.76	0.00	0.76	1.90
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	60.82	17.42	4.60	5.26	8.55	1.97	0.33	0.99	0.33	0.99
CD14+ monocytes - mock treated, donor1	11863-125A9	27.75	7.95	2.89	2.17	2.46	1.16	1.30	1.01	0.87	2.02
CD14+ monocytes - mock treated, donor2	11873-125C1	18.10	2.72	2.72	0.91	0.60	1.21	0.60	1.81	0.00	1.51
CD14+ monocytes - mock treated, donor3	11883-125D2	26.77	7.82	4.03	1.18	2.13	0.95	0.95	1.42	0.71	1.42
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	18.58	7.53	1.00	1.67	1.00	1.00	1.17	0.33	0.33	1.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	13.80	4.69	1.93	1.38	0.55	0.28	0.00	0.28	0.28	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	18.35	5.70	2.48	0.74	1.98	0.25	0.00	0.50	0.50	0.99
CD14+ monocytes - treated with BCG, donor1	11860-125A6	19.97	6.85	1.57	1.76	0.78	0.59	0.98	0.20	0.00	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	20.83	3.20	4.63	0.89	1.07	1.07	0.36	0.18	0.36	0.36
CD14+ monocytes - treated with BCG, donor3	11880-125C8	28.73	8.27	5.22	1.52	0.44	1.31	0.65	0.87	0.22	1.52
CD14+ monocytes - treated with Candida, donor1	11868-125B5	25.29	4.68	3.28	2.34	0.70	0.70	0.47	0.23	0.00	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	22.71	6.34	2.11	0.53	1.06	0.53	0.00	0.00	0.00	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	25.52	9.98	1.11	0.00	1.11	1.11	0.00	0.00	1.11	2.22
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	22.91	3.27	2.53	1.93	1.04	0.59	0.89	1.04	0.15	1.34
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	14.17	4.79	3.59	1.20	1.00	1.20	0.20	0.40	0.40	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	25.19	7.70	2.29	1.04	1.04	1.25	1.04	0.62	0.42	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	21.05	9.61	1.37	2.52	1.14	1.60	1.60	1.83	0.46	2.52
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	20.36	6.56	4.98	0.68	0.68	0.45	0.90	1.58	0.68	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	18.77	6.98	3.06	0.87	1.31	0.87	0.00	0.87	0.44	3.06
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	25.02	8.34	2.69	2.42	1.08	1.34	0.81	0.81	0.54	1.34
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	26.87	5.06	2.79	0.87	1.40	1.57	0.87	1.05	0.52	1.05
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	25.25	13.47	6.73	0.84	1.68	1.26	0.84	0.84	0.84	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	18.92	5.70	1.29	2.02	0.92	0.92	1.47	0.55	0.73	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	16.20	3.17	1.76	0.35	1.41	0.35	0.00	0.70	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	14.92	8.77	3.51	1.32	1.75	0.88	0.44	0.44	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	21.97	5.41	1.57	1.74	1.22	0.00	0.17	0.70	0.35	1.22
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	20.81	4.09	1.86	0.37	1.49	0.74	1.12	0.74	0.00	1.86
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	32.55	5.82	3.45	0.86	1.08	1.29	0.65	0.22	0.22	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	18.84	9.42	0.82	0.00	0.41	1.64	0.41	0.00	1.23	1.23
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	21.56	5.10	1.16	0.46	0.93	0.70	0.46	0.70	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	24.82	7.19	2.32	0.23	0.93	0.23	0.23	0.70	0.46	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	60.38	11.12	5.89	4.80	3.71	1.96	0.87	0.65	0.44	0.87
CD14+CD16+ Monocytes, donor2	11801-124D1	51.97	11.32	9.47	5.31	3.23	2.54	1.85	1.62	0.00	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	68.02	10.40	9.96	3.25	4.77	2.17	0.87	2.17	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	72.41	9.03	3.74	5.14	5.92	1.87	1.40	1.09	0.47	1.87
CD14+CD16- Monocytes, donor2	11799-124C8	68.81	9.43	2.79	4.37	3.14	3.32	0.17	1.57	0.87	1.57
CD14+CD16- Monocytes, donor3	11910-125G2	70.24	10.48	4.46	3.34	3.57	1.78	1.11	0.45	0.22	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	43.38	4.85	6.63	3.83	3.57	1.53	0.77	0.26	0.00	1.28
CD14-CD16+ Monocytes, donor2	11800-124C9	30.96	7.03	9.66	6.15	2.63	1.10	1.10	0.22	0.66	1.54
CD14-CD16+ Monocytes, donor3	11911-125G3	50.11	7.79	20.63	5.68	3.37	1.26	1.05	1.05	0.42	0.63
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	42.68	6.10	0.00	4.06	0.00	0.00	0.00	0.00	2.03	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	41.36	6.78	4.07	0.68	2.03	0.00	0.00	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	40.39	3.11	5.18	4.14	0.00	0.00	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	27.72	2.67	1.07	1.60	0.53	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	26.27	2.14	1.07	0.54	1.07	0.00	0.00	0.00	0.00	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	31.59	4.21	2.81	0.00	0.70	0.00	0.00	0.00	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	28.24	3.92	1.57	1.57	0.00	0.00	0.00	0.78	0.00	3.92
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	25.05	1.32	5.27	1.32	2.64	0.00	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	23.84	2.47	0.82	0.82	0.00	0.00	0.00	0.00	0.00	2.47
CD19+ B Cells, donor2	11624-122B4	24.66	2.90	0.73	0.73	0.73	0.00	0.00	0.00	0.00	0.73
CD19+ B Cells, donor3	11705-123B4	11.11	1.01	0.00	0.50	0.00	0.00	0.00	0.00	0.00	3.03
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	4.04	1.21	0.00	0.40	0.40	0.00	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.40	0.40	0.40	1.20	0.80	0.40	0.00	0.40	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	52.21	6.02	11.04	2.01	4.02	1.00	1.00	0.00	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	46.63	12.36	10.67	2.81	2.81	0.00	0.00	0.00	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	68.01	9.77	9.77	4.51	5.64	0.75	1.13	0.75	1.50	1.13
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	69.45	18.04	11.50	4.28	4.51	2.03	0.68	1.58	1.13	0.90
CD4+ T Cells, donor1	11225-116C1	22.85	1.79	1.07	2.14	1.79	0.00	0.36	0.36	0.36	2.86
CD4+ T Cells, donor2	11306-117C1	18.37	5.51	2.45	0.61	0.61	0.00	0.00	0.00	0.00	1.22
CD4+ T Cells, donor3	11382-118B5	16.77	1.22	5.79	1.22	0.91	0.00	0.00	0.00	0.00	0.61
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	5.36	0.26	1.28	0.26	0.51	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	5.17	0.22	0.22	0.22	0.22	0.00	0.00	0.22	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	8.34	0.00	0.86	0.29	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	64.48	5.22	7.11	4.74	2.84	1.42	0.47	0.95	0.47	1.42
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	61.80	5.62	7.02	7.02	2.11	0.70	0.00	1.40	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	102.18	6.59	13.18	3.30	3.30	0.00	0.00	0.00	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	10.41	0.29	1.01	0.29	0.58	0.00	0.00	0.14	0.00	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	1.19	0.34	0.17	0.17	0.17	0.00	0.00	0.34	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	3.87	0.16	0.81	0.64	0.00	0.00	0.00	0.00	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	7.17	0.45	0.45	0.45	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	8.39	0.70	0.70	0.35	0.00	0.00	0.00	0.35	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	5.28	0.00	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	24.88	2.11	0.42	1.26	0.00	0.00	0.00	0.00	0.42	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	13.30	1.04	0.62	0.62	0.62	0.00	0.00	0.00	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	17.71	0.00	4.34	0.00	1.00	0.00	0.00	0.33	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	38.61	3.81	2.45	2.45	2.72	0.27	0.00	0.54	0.54	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	42.34	3.75	2.14	2.14	3.22	0.00	0.00	0.00	0.54	2.68
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	14.35	5.38	12.55	5.38	1.79	0.00	0.00	1.79	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	8.53	1.85	0.19	0.37	0.19	0.00	0.00	0.19	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	2.17	0.22	0.22	0.65	0.22	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	4.41	0.00	1.26	0.63	0.21	0.00	0.00	0.21	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	19.72	2.53	0.51	1.52	2.02	0.00	0.00	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	19.06	1.73	3.90	1.30	0.00	0.43	0.00	0.43	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	23.10	3.49	3.92	2.18	2.18	0.00	0.00	0.00	0.00	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	43.05	15.84	10.39	4.95	2.97	0.49	0.00	0.49	0.49	1.98
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	37.85	7.39	12.00	7.39	3.69	0.00	0.00	0.00	0.92	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	47.46	12.56	8.37	6.98	5.58	2.79	0.00	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	61.20	11.35	6.65	6.37	2.77	0.55	0.00	0.28	0.83	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	62.57	12.02	7.36	8.34	4.42	0.25	0.00	0.98	3.68	1.47
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	41.58	6.16	21.56	4.62	10.78	0.00	0.00	1.54	0.00	4.62
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	41.18	12.89	8.24	8.24	2.51	0.36	0.00	0.72	1.07	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	56.78	16.62	9.69	9.69	1.38	1.38	0.00	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	38.31	4.91	2.29	1.96	1.64	0.33	0.00	0.33	0.00	2.29
CD8+ T Cells, donor2	11307-117C2	29.28	8.63	4.13	1.88	1.13	0.38	0.00	0.38	1.13	1.50
CD8+ T Cells, donor3	11383-118B6	33.33	5.81	3.79	1.77	2.27	0.25	0.25	0.50	1.01	2.27
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	38.54	5.05	1.15	0.92	0.46	0.69	1.38	0.23	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	33.55	4.79	1.20	0.96	0.72	0.96	0.48	0.24	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	30.10	3.56	1.37	1.37	0.82	0.55	0.82	0.55	0.00	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	31.52	6.30	1.20	1.50	0.60	0.60	0.60	0.00	0.30	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	34.56	5.76	1.20	1.20	1.20	0.72	0.72	0.48	0.24	0.48
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	33.65	4.09	1.82	1.59	0.91	0.23	0.91	0.23	0.23	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	29.55	7.60	0.65	1.30	0.65	0.00	0.87	0.43	0.00	0.87
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	30.53	7.90	1.05	0.79	0.53	1.58	1.32	0.26	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	33.54	7.50	0.70	0.47	1.41	0.70	1.17	1.17	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	40.75	13.58	1.21	0.91	1.51	0.60	2.11	0.91	0.30	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	38.06	6.68	1.16	2.03	0.58	0.87	1.16	0.58	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	43.70	7.73	1.87	1.33	1.33	1.07	0.53	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	27.58	7.00	0.44	0.88	0.44	0.88	1.75	0.88	0.88	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	35.07	8.65	0.46	2.28	0.00	0.00	0.46	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	30.58	6.71	0.00	0.75	0.75	1.49	1.49	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	30.61	5.04	0.00	0.36	1.08	1.80	1.08	1.08	0.00	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	33.66	3.45	2.30	1.44	0.86	0.86	0.58	0.00	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	36.30	6.84	0.94	1.18	0.47	0.71	0.94	0.47	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	32.64	4.75	0.63	0.95	0.00	0.95	0.63	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	35.98	5.54	0.92	1.23	0.92	1.23	1.23	0.62	0.00	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	33.02	4.17	0.96	0.64	1.92	1.60	0.64	0.00	1.28	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	35.19	9.56	1.15	1.91	1.15	1.91	0.76	0.38	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	44.53	5.12	1.58	0.79	0.79	0.39	0.39	0.39	0.00	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	40.85	10.59	0.76	0.00	0.76	1.51	0.00	0.76	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	33.72	8.83	0.00	0.00	0.00	1.61	1.61	0.00	0.00	3.21
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	34.27	4.90	2.10	2.10	1.40	0.70	0.00	2.80	0.00	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	36.06	4.01	0.00	1.00	0.00	0.00	0.00	1.00	0.00	2.00
Cardiac Myocyte, donor1	11525-119I4	27.42	5.48	1.83	3.66	1.83	3.66	0.00	0.00	0.00	1.83
Cardiac Myocyte, donor2	11605-120I3	28.66	24.70	8.40	6.42	4.45	5.43	5.43	1.48	1.98	0.00
Cardiac Myocyte, donor3	11686-122I3	28.10	18.42	13.47	6.10	3.79	4.10	3.26	2.63	1.79	0.11
Chondrocyte - de diff, donor1	11261-116G1	34.67	13.17	6.24	6.24	2.43	3.12	1.04	2.43	2.08	0.00
Chondrocyte - de diff, donor2	11338-117F6	21.32	13.50	15.64	3.20	3.55	4.62	3.55	3.20	1.07	0.00
Chondrocyte - de diff, donor3	11410-118E6	27.99	8.87	12.86	4.10	3.64	2.62	3.07	2.28	0.57	0.11
Chondrocyte - re diff, donor2	11339-117F7	24.17	15.22	12.53	8.95	5.37	2.69	1.79	1.79	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	28.71	8.90	14.56	6.87	4.85	2.02	1.21	2.83	0.81	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	27.31	17.56	16.75	9.30	4.36	3.44	4.36	1.72	1.15	1.15
Ciliary Epithelial Cells, donor2	11323-117D9	18.81	11.97	10.47	6.63	4.28	2.57	2.14	1.50	1.28	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	18.58	16.64	9.12	5.31	5.22	3.89	3.27	1.59	1.24	0.62
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	43.37	14.03	6.79	5.14	3.30	3.12	2.75	1.56	1.56	3.48
Corneal Epithelial Cells, donor1	11526-119I5	19.10	7.03	7.25	4.39	1.76	0.22	0.22	0.44	0.66	0.00
Corneal Epithelial Cells, donor2	11606-120I4	6.83	7.96	4.55	2.28	0.00	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	12.78	6.90	8.18	4.60	3.58	0.77	0.77	0.51	0.77	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	31.37	19.65	4.13	4.46	2.15	0.00	0.17	0.33	0.17	1.49
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	41.00	22.71	3.78	5.68	3.47	0.00	0.00	0.32	0.32	1.26
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	20.70	3.45	3.45	3.45	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	27.32	25.59	7.88	5.83	4.00	0.65	0.43	0.43	0.43	1.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	6.15	1.71	1.02	0.34	0.34	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	11.10	1.31	1.31	0.65	0.65	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	12.58	1.94	0.97	0.48	0.97	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	32.19	19.68	14.01	9.51	4.34	1.17	2.33	0.83	0.67	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	23.47	23.47	12.32	8.80	1.76	2.93	2.93	2.93	0.59	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	26.30	10.18	8.48	3.96	2.83	1.98	2.83	1.41	0.00	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	27.92	15.73	7.47	3.93	2.36	3.15	3.15	2.75	1.97	0.00
Endothelial Cells - Artery, donor1	11264-116G4	23.27	21.82	7.85	6.11	6.11	5.24	3.78	1.16	0.87	0.00
Endothelial Cells - Artery, donor2	11341-117F9	25.65	20.94	13.18	6.82	4.00	4.71	2.12	1.18	1.41	0.94
Endothelial Cells - Artery, donor3	11413-118E9	25.77	27.52	8.77	5.79	4.03	4.73	3.33	1.93	1.40	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	22.17	46.10	11.97	11.53	7.09	5.54	5.32	3.32	3.10	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	15.82	41.08	12.78	10.95	8.52	3.96	1.83	0.91	0.91	2.13
Endothelial Cells - Lymphatic, donor3	11393-118C7	15.50	19.17	5.64	8.74	3.38	3.38	2.82	1.97	0.85	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	26.15	21.10	14.86	5.94	4.16	2.08	0.89	2.97	1.19	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	54.67	51.55	7.29	7.29	5.21	4.17	5.73	2.08	1.56	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	25.66	13.04	18.72	4.82	3.97	2.55	4.96	1.84	1.13	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	35.21	21.21	11.60	7.60	6.00	3.60	1.60	2.80	2.80	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	25.16	16.77	5.24	7.34	4.19	4.19	3.14	1.05	1.05	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	40.50	46.84	16.40	10.56	7.95	3.23	4.22	1.99	3.98	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	36.28	19.34	11.73	5.43	7.39	1.96	2.61	0.87	2.61	1.30
Endothelial Cells - Umbilical vein, donor3	11400-118D5	29.55	26.14	6.59	6.72	4.52	3.18	2.56	0.61	2.69	0.61
Endothelial Cells - Vein, donor1	11267-116G7	19.34	18.20	6.83	4.55	3.41	4.55	1.14	1.14	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	25.84	36.32	5.59	4.89	4.89	2.10	5.59	4.19	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	31.56	19.00	7.85	8.95	5.02	3.45	4.08	1.57	1.10	0.31
Eosinophils, donor1	12244-129H3	45.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	19.80	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	7.13	3.57	0.00	3.57	3.57	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	11.24	6.60	6.60	2.93	0.73	0.98	0.24	0.24	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	10.40	2.08	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	19.29	12.73	8.21	6.98	4.52	3.69	3.69	2.46	1.64	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	9.31	12.81	4.38	1.75	1.31	2.63	1.86	1.97	0.88	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	20.48	12.13	8.13	5.20	1.52	5.74	4.55	4.33	1.30	0.00
Fibroblast - Aortic Adventitial, donor1	11245-116E3	22.56	15.04	3.40	3.64	2.43	2.79	2.67	2.91	0.97	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	12.42	26.75	4.50	5.60	2.05	1.91	2.18	1.91	1.91	2.73
Fibroblast - Aortic Adventitial, donor2	11326-117E3	9.60	9.18	8.23	3.27	1.48	3.48	2.11	2.11	0.42	0.21
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	12.12	15.02	5.01	2.11	1.58	2.11	1.05	1.84	2.37	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	18.27	13.95	10.30	4.32	3.32	3.65	2.99	1.99	1.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	19.05	17.69	6.35	6.35	5.90	3.63	6.80	2.27	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	19.71	12.89	6.06	4.55	2.27	3.03	5.31	3.03	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	13.56	10.09	5.36	5.99	2.52	4.57	2.21	2.21	0.79	0.00
Fibroblast - Cardiac, donor4	11452-119A3	16.67	10.91	5.15	4.24	3.03	2.12	2.12	1.21	0.61	0.30
Fibroblast - Cardiac, donor5	11456-119A7	26.52	15.36	9.14	4.82	2.16	2.79	2.41	0.89	1.02	0.00
Fibroblast - Cardiac, donor6	11460-119B2	18.49	18.19	10.31	8.03	4.55	1.82	1.82	1.52	1.06	0.76
Fibroblast - Choroid Plexus, donor1	11492-119E7	17.15	7.50	9.11	3.89	1.74	1.74	1.34	1.07	0.54	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.94	7.33	13.81	5.18	0.86	1.73	0.43	0.86	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	35.16	13.18	10.25	5.86	1.46	1.46	1.46	1.46	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	35.06	10.15	6.00	7.38	2.54	2.31	2.31	0.92	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	12.89	35.28	23.07	4.92	5.26	3.56	5.09	1.53	0.85	0.00
Fibroblast - Dermal, donor1	11269-116G9	29.35	13.38	10.33	6.57	2.82	4.46	0.23	1.17	1.17	0.00
Fibroblast - Dermal, donor2	11346-117G5	36.32	28.30	11.79	6.60	6.60	0.47	3.77	0.47	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	32.28	12.93	8.46	6.89	3.87	2.30	3.26	0.97	1.21	0.36
Fibroblast - Dermal, donor4	11450-119A1	18.88	8.48	8.48	7.12	2.83	1.02	0.79	0.68	0.11	0.57
Fibroblast - Dermal, donor5	11454-119A5	23.03	15.70	7.33	7.85	3.49	2.09	1.57	0.17	0.17	0.35
Fibroblast - Dermal, donor6	11458-119A9	25.34	15.76	6.66	7.15	4.22	1.62	0.81	0.32	0.65	0.65
Fibroblast - Gingival, donor1	11237-116D4	47.68	38.73	9.79	7.08	8.95	3.33	2.71	1.04	0.83	1.25
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	32.49	25.41	12.31	7.60	4.19	4.72	3.67	1.83	1.05	0.52
Fibroblast - Gingival, donor2	11318-117D4	34.40	30.05	10.94	11.73	6.19	2.50	1.71	1.58	1.32	1.32
Fibroblast - Gingival, donor3	11394-118C8	33.94	23.78	9.86	6.09	5.22	2.42	2.42	0.77	1.16	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	22.86	8.31	5.19	5.19	0.00	2.08	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	21.67	6.52	5.81	1.59	1.59	2.47	1.76	1.41	0.18	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	30.24	30.40	6.39	6.24	4.37	3.12	3.27	1.56	1.56	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	29.75	26.10	4.06	6.90	3.65	3.11	1.22	1.76	0.81	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	9.88	8.47	0.35	1.76	1.76	1.06	1.41	2.82	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	24.28	25.59	8.63	7.46	3.36	4.53	4.53	1.46	1.02	0.29
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	22.09	32.59	6.95	7.09	3.00	4.09	2.59	2.86	0.68	1.09
Fibroblast - Gingival, donor8 (control)	11926-125H9	22.38	14.81	3.40	4.28	2.96	3.07	1.21	1.10	0.33	0.44
Fibroblast - Gingival, donor9 (control)	11927-125I1	21.57	12.33	7.34	3.67	3.08	5.14	1.61	2.05	1.61	0.44
Fibroblast - Lung, donor1	11270-116H1	24.47	19.03	5.44	6.80	0.00	2.72	1.36	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	43.27	20.89	4.48	8.95	1.49	7.46	1.49	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	37.99	21.31	13.72	8.86	7.60	5.70	4.22	1.48	1.06	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	36.65	11.66	7.50	5.83	2.50	8.33	0.83	2.50	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	18.18	13.99	8.39	5.59	2.80	0.00	1.40	0.00	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	13.99	5.60	4.76	3.64	0.56	0.84	0.84	0.84	0.28	0.00
Fibroblast - Mammary, donor1	11540-120B1	33.70	16.24	6.09	6.09	3.25	0.81	1.22	1.22	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	15.98	3.99	7.99	0.00	0.00	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	23.83	5.96	11.91	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	32.01	31.62	15.32	10.67	7.18	2.13	2.52	1.36	0.39	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	32.31	21.84	12.44	6.07	4.85	3.34	3.49	1.21	1.52	0.76
Fibroblast - Periodontal Ligament, donor3	11395-118C9	33.05	24.17	5.20	6.43	4.59	2.14	1.84	1.22	1.53	1.22
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	20.61	14.88	3.82	5.72	1.91	2.67	1.91	0.00	1.14	0.38
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	31.32	16.20	7.29	6.48	2.97	3.78	0.81	2.16	1.35	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	16.82	6.61	5.80	3.02	1.74	3.25	1.51	1.16	0.23	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	23.21	25.86	8.29	5.75	4.31	2.87	2.87	2.10	1.11	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	23.37	9.96	6.91	4.06	3.66	1.63	2.03	1.02	0.61	0.61
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	30.74	26.73	16.71	13.36	6.01	3.34	2.00	2.00	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	17.00	18.58	22.14	5.93	3.95	2.37	3.16	1.98	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	17.07	25.20	6.55	5.75	2.78	3.18	1.79	1.79	1.98	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	24.33	10.83	7.64	2.49	2.66	1.60	2.31	1.42	0.36	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	18.53	8.28	8.47	3.94	1.77	2.17	1.38	1.77	0.39	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	18.65	17.75	3.91	6.02	1.50	2.41	0.60	1.81	0.90	1.20
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	26.02	17.27	7.02	7.12	3.56	3.67	1.40	2.37	0.97	1.19
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	14.43	14.68	11.64	4.81	2.53	3.04	1.52	1.27	0.25	0.25
Fibroblast - skin normal, donor1	11553-120C5	26.25	10.67	13.29	3.28	2.13	1.97	2.13	1.31	0.82	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	15.04	21.25	5.81	6.42	2.81	2.41	1.80	2.01	1.60	1.40
Fibroblast - skin normal, donor2	11561-120D4	19.49	14.37	7.94	6.23	1.91	2.51	2.11	2.31	0.80	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	17.83	27.20	15.41	6.95	1.51	2.72	0.30	3.02	2.42	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	18.89	8.70	15.08	4.64	1.91	2.15	2.32	1.24	0.75	0.41
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	22.57	20.17	14.87	4.79	2.39	3.42	2.05	3.59	1.03	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	12.15	14.78	4.60	3.28	3.61	2.63	1.97	1.31	1.31	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	22.69	19.39	7.03	6.39	3.41	2.02	1.70	0.85	0.53	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	21.25	23.45	8.77	6.41	3.88	3.54	1.86	1.01	1.18	0.51
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	25.56	18.50	12.70	5.02	4.23	2.98	2.04	2.35	2.04	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	199.44	177.28	22.16	22.16	66.48	66.48	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	2.61	0.87	0.00	0.87	1.74	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	13.35	18.38	6.07	6.41	4.33	1.39	0.69	0.87	1.04	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	15.35	15.09	6.25	5.20	1.56	0.78	0.52	0.78	1.56	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	11.75	10.48	5.62	5.62	2.81	1.02	0.51	0.00	1.28	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	16.08	6.89	9.19	3.06	2.30	0.77	0.77	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	12.76	8.93	6.38	0.64	1.28	0.64	1.28	0.64	1.28	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	11.70	6.28	4.56	0.86	1.43	0.29	0.00	0.29	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	4.69	0.55	0.83	0.28	0.00	0.00	0.28	0.00	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	4.57	1.60	1.14	0.91	0.68	0.00	0.23	0.46	0.46	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	10.50	3.57	2.97	1.98	0.99	0.00	0.20	0.59	0.59	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	5.55	0.53	0.00	0.26	0.53	0.26	0.00	0.53	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	4.57	2.28	0.65	0.65	1.63	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	15.92	1.77	5.31	3.10	0.00	0.00	0.44	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	11.02	4.95	5.51	3.25	0.71	0.00	0.28	0.00	0.71	0.14
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	10.10	3.20	3.32	2.59	0.86	0.62	0.49	0.25	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	10.48	8.06	2.95	1.07	1.07	0.81	0.00	1.07	0.81	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	9.79	3.72	4.83	2.23	1.61	0.25	0.50	0.00	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	11.07	5.95	4.29	2.49	1.25	0.00	0.28	0.00	0.14	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	10.78	5.29	5.69	1.22	0.61	0.61	0.20	0.41	0.61	0.41
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	14.15	6.39	9.36	3.65	1.60	0.00	0.46	0.00	0.68	0.68
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	14.33	9.47	10.09	3.74	1.62	0.50	0.25	0.00	0.50	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	13.99	9.18	8.74	3.72	1.75	0.66	0.87	0.44	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	11.82	9.16	10.64	7.68	2.36	0.00	0.00	0.30	2.07	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	12.08	7.15	8.27	3.81	1.11	0.32	0.48	0.64	0.48	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	12.73	7.15	6.48	2.68	0.45	0.67	0.45	0.89	1.34	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	11.49	8.47	10.69	4.03	2.22	0.60	0.60	0.40	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	12.72	6.79	10.35	3.73	1.02	0.17	0.51	0.17	1.19	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	8.42	9.13	6.21	3.64	1.86	1.06	0.18	0.62	0.44	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	16.44	5.62	15.71	4.58	1.66	0.21	1.04	0.62	0.10	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	17.08	5.12	14.52	5.12	0.85	0.34	1.37	1.02	0.17	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	15.38	8.52	13.94	4.87	2.43	0.22	1.55	0.77	0.77	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	10.57	10.07	7.82	3.16	1.66	0.58	0.58	0.67	0.75	0.67
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	12.05	11.23	7.76	4.70	2.45	0.82	0.61	1.02	0.82	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	13.20	5.98	10.52	5.57	1.03	1.86	0.83	0.83	0.62	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	16.72	5.53	13.72	4.96	2.65	0.46	1.04	0.58	0.69	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	11.51	7.00	10.01	4.34	1.00	0.67	0.67	1.00	0.67	0.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	14.77	3.31	14.33	3.53	1.76	0.66	0.44	0.44	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	20.91	5.53	18.08	4.80	2.21	0.49	0.86	0.25	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	11.18	10.21	11.35	6.65	2.92	1.13	0.97	0.32	0.49	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	17.64	5.77	20.21	6.09	2.25	0.96	0.64	0.32	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	15.44	7.49	18.67	6.63	2.37	0.95	1.80	0.57	0.57	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	11.71	10.60	16.29	6.33	3.16	1.27	0.95	0.32	0.32	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	11.56	6.08	14.60	5.47	0.91	0.61	0.61	0.00	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	12.44	5.33	13.90	4.91	1.78	0.73	1.15	1.05	0.52	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	15.15	14.27	17.34	10.76	4.83	0.66	2.20	0.22	1.76	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	13.19	7.29	14.03	5.89	2.52	0.84	1.12	0.28	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	11.85	4.54	12.31	5.09	1.76	1.30	1.02	0.83	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	10.96	13.10	10.96	6.69	2.67	1.34	2.67	0.80	1.07	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	8.57	6.12	11.48	5.20	0.61	0.77	1.07	0.92	0.31	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	7.38	5.18	12.82	4.79	2.85	1.04	1.17	0.65	0.52	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	11.66	15.72	19.52	9.22	5.69	1.36	1.90	1.63	1.08	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	9.95	5.16	15.67	7.19	2.03	1.66	1.11	0.37	0.37	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	10.09	7.68	12.50	5.92	3.51	1.54	1.10	1.10	0.66	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	9.92	9.92	9.92	8.93	0.00	1.98	3.97	2.98	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	8.18	7.12	11.34	5.28	2.24	1.85	1.58	0.92	0.40	0.66
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	9.28	8.27	9.48	5.65	2.02	1.21	1.01	0.81	1.01	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	7.12	8.64	7.37	2.80	2.29	0.76	1.52	0.00	0.51	0.25
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	12.94	2.99	2.79	0.40	0.40	0.20	0.00	0.00	1.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	5.39	0.92	2.16	0.77	0.62	0.00	0.31	0.00	0.31	0.31
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	10.64	0.82	2.25	1.23	0.61	0.00	0.00	0.61	0.82	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	5.63	2.19	1.88	0.94	0.63	0.31	0.31	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	7.91	3.39	0.85	1.70	0.28	0.00	0.00	0.28	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	5.53	2.77	0.00	0.92	0.92	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	7.42	2.47	9.90	2.47	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	8.90	7.74	3.09	3.09	0.77	0.39	0.00	0.77	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	8.02	12.84	4.81	1.60	0.00	0.00	0.00	0.00	4.81	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	5.22	6.96	3.48	1.74	0.00	0.00	1.74	0.00	3.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	7.16	10.42	2.60	0.65	0.65	0.65	0.65	0.33	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	9.06	9.88	3.29	3.71	1.24	0.00	1.24	1.24	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	3.33	6.66	6.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	9.51	8.39	3.64	3.08	1.68	1.12	0.56	0.84	0.56	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	8.82	12.42	3.60	2.94	3.27	0.33	0.33	1.31	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	8.39	4.19	0.84	2.52	0.84	0.00	0.84	0.00	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	10.50	8.91	0.64	3.18	1.91	0.32	0.00	0.64	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	8.83	11.89	2.38	2.72	1.02	0.34	0.34	0.00	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	8.35	2.09	10.44	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	17.75	9.16	4.58	5.15	2.29	1.15	0.00	0.57	0.57	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	16.28	9.18	4.74	4.44	4.14	0.59	0.00	0.89	0.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	6.78	22.02	3.39	6.78	3.39	3.39	0.00	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	13.67	12.01	1.24	4.14	3.73	1.24	0.41	1.24	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	11.74	9.90	1.38	2.53	1.15	0.46	0.69	0.46	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	26.34	10.54	15.81	5.27	5.27	5.27	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	15.76	19.99	1.15	3.84	2.31	1.15	0.77	1.15	1.92	0.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	15.32	18.25	3.59	4.24	3.91	1.63	0.65	0.00	1.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	24.08	24.08	4.68	3.34	2.68	2.01	1.34	2.01	2.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	26.58	20.80	2.31	4.24	2.31	0.77	0.39	0.77	1.54	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	17.12	15.75	4.45	3.77	2.40	1.03	0.68	1.37	1.37	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	24.85	17.39	7.45	4.97	2.48	2.48	2.48	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	33.50	10.38	5.19	4.25	1.42	0.47	0.47	0.94	2.36	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	29.57	17.50	3.62	2.41	3.02	0.60	1.21	0.60	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	20.35	12.21	4.07	5.09	1.53	1.02	1.02	1.53	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	19.94	15.55	3.99	5.58	1.99	2.39	0.40	0.40	1.20	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	25.65	17.27	8.39	4.93	4.44	3.45	0.49	0.99	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	33.05	11.80	3.54	1.18	1.18	3.54	1.18	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	32.09	18.67	8.75	6.42	5.25	1.75	1.75	1.17	1.75	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	21.07	15.80	2.63	4.83	2.63	1.32	0.88	1.76	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	22.89	8.48	6.78	2.54	1.70	0.85	0.85	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	22.09	16.71	4.78	1.79	3.58	0.60	1.19	1.19	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	21.35	16.01	4.85	3.40	2.91	1.46	1.94	2.43	1.46	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	19.40	15.98	4.57	5.71	1.14	0.00	1.14	2.28	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	9.15	6.65	4.16	4.16	1.25	0.42	1.66	0.42	0.42	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	22.49	24.74	22.49	9.00	1.12	2.25	5.62	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	17.76	5.39	16.49	3.81	1.59	1.27	0.95	0.00	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	15.87	10.86	10.86	2.92	1.25	0.84	1.67	1.25	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	44.56	28.31	8.36	7.54	5.45	4.41	2.44	3.13	2.09	0.35
Hep-2 cells mock treated, biol_rep2	11899-125E9	45.07	28.53	9.12	8.95	6.08	6.25	0.84	3.54	1.35	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	50.28	34.35	7.28	11.15	7.28	3.19	2.28	1.14	1.59	1.37
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	44.82	33.23	6.67	9.51	8.64	4.15	3.17	3.39	1.64	0.55
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	44.49	30.95	5.59	8.38	7.09	6.23	2.58	2.58	1.29	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	44.56	40.26	7.75	10.12	8.83	4.09	3.23	1.72	1.51	0.65
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	41.60	31.51	6.23	10.21	6.35	6.10	1.87	3.36	1.37	0.62
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	42.20	28.65	6.86	8.92	5.66	3.77	2.40	1.72	1.72	0.34
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	43.89	29.47	7.37	8.33	6.41	3.52	2.56	2.24	1.28	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	41.41	70.51	10.63	13.43	7.83	7.28	7.28	1.12	2.80	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	16.88	8.66	9.09	3.46	3.03	2.60	3.46	2.60	0.87	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	31.73	0.00	2.64	2.64	2.64	0.00	2.64	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	27.16	22.93	7.41	7.76	3.17	5.64	3.17	4.94	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	13.08	16.71	9.44	6.54	2.91	5.09	6.54	2.18	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	20.63	22.38	8.39	5.42	3.50	4.90	2.97	1.75	1.05	0.00
Hepatocyte, donor1	11523-119I2	7.26	3.63	2.42	2.42	0.00	0.00	1.21	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	22.62	5.39	1.08	1.08	3.23	2.15	0.00	0.00	2.15	1.08
Hepatocyte, donor3	11684-122I1	16.57	7.36	7.36	3.68	1.84	6.14	3.07	1.23	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	12.58	12.93	5.07	4.19	2.62	0.17	1.05	0.17	0.87	0.52
Iris Pigment Epithelial Cells, donor1	11530-119I9	19.35	18.93	7.68	7.68	3.57	2.06	3.16	1.10	2.06	0.69
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	47.76	25.47	3.18	0.00	6.37	0.00	9.55	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	26.70	13.35	6.68	6.68	13.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	49.84	16.61	2.77	9.69	1.38	2.77	5.54	0.00	1.38	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	37.54	22.52	5.01	10.01	2.50	7.51	2.50	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	23.74	0.00	0.00	11.87	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	46.13	15.38	7.69	5.13	10.25	0.00	7.69	2.56	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	77.70	22.85	4.57	0.00	0.00	4.57	9.14	4.57	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	55.23	12.99	14.62	14.62	4.87	4.87	3.25	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	61.69	16.67	10.00	15.01	3.33	3.33	3.33	5.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	79.87	10.89	14.52	10.89	0.00	10.89	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	43.67	18.53	13.23	5.29	2.65	5.29	6.62	3.97	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	42.13	21.06	5.54	9.98	6.65	6.65	3.33	3.33	2.22	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	89.05	20.95	0.00	15.71	0.00	10.48	0.00	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	53.54	20.79	11.97	10.71	5.67	6.30	5.67	2.52	0.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	49.49	17.01	6.19	9.28	6.19	9.28	1.55	4.64	1.55	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	14.63	0.00	14.63	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	41.99	16.80	13.57	5.17	5.17	5.17	5.17	1.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	62.79	12.88	11.27	14.49	3.22	8.05	6.44	0.00	0.00	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	11.95	23.90	0.00	0.00	11.95	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	47.26	23.63	10.59	9.78	4.89	5.70	4.89	1.63	0.81	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	47.44	17.21	6.30	7.14	4.20	4.62	5.04	3.78	1.68	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	86.23	43.12	0.00	14.37	0.00	0.00	14.37	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	53.85	24.11	9.64	9.64	5.63	5.63	5.63	5.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	35.08	12.00	11.08	3.69	3.69	4.62	2.77	2.77	0.92	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	90.48	15.08	0.00	0.00	0.00	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	48.62	17.94	8.02	7.08	3.30	2.36	4.25	1.89	0.94	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	48.98	16.33	7.26	4.53	6.35	9.98	1.81	2.72	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	44.23	44.23	29.48	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	53.81	21.52	11.84	7.53	3.23	3.23	6.46	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	48.28	24.14	11.43	7.62	7.62	5.08	6.35	1.27	1.27	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	98.58	16.43	32.86	16.43	0.00	0.00	0.00	16.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	51.01	26.78	7.65	3.19	1.91	3.83	3.83	3.19	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	21.87	14.58	14.58	5.47	1.82	5.47	0.00	1.82	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	79.02	0.00	0.00	0.00	0.00	0.00	0.00	31.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	44.27	9.28	12.14	8.57	4.28	5.71	5.00	3.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	39.82	13.27	16.59	9.95	6.64	6.64	0.00	3.32	3.32	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	41.70	0.00	20.85	0.00	0.00	20.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	48.15	16.67	10.49	6.48	5.56	4.01	5.86	4.01	1.23	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	54.44	5.27	14.05	5.27	3.51	1.76	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	28.29	22.00	9.43	9.43	3.14	9.43	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	46.59	11.82	4.87	9.04	3.48	6.26	2.78	2.78	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	81.88	19.92	26.56	8.85	6.64	17.70	4.43	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	42.15	9.73	3.24	12.97	6.48	16.21	6.48	0.00	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	58.42	26.16	15.69	12.21	5.23	6.98	6.10	6.10	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	87.74	29.25	13.50	11.25	4.50	2.25	4.50	2.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	45.30	31.36	3.48	3.48	0.00	10.45	3.48	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	77.87	22.40	13.87	13.87	3.20	4.27	7.47	1.07	3.20	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	37.41	18.01	6.93	8.31	1.39	4.16	6.93	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	17.10	14.25	11.40	5.70	0.00	0.00	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	45.10	19.33	4.60	6.44	3.68	6.44	5.52	1.84	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	60.51	24.20	21.18	9.08	12.10	12.10	6.05	3.03	6.05	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	68.30	24.83	12.42	6.21	0.00	0.00	0.00	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	49.70	11.63	24.32	11.63	10.57	5.29	4.23	2.11	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	9.06	18.12	2.86	3.02	1.39	0.41	0.41	1.06	0.65	0.08
Keratinocyte - epidermal, donor2	11349-117G8	11.71	8.20	2.34	3.51	2.34	0.59	0.59	0.59	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	9.75	5.02	6.25	3.69	2.37	0.85	0.09	0.47	0.19	0.19
Keratinocyte - oral, donor1	11251-116E9	21.23	6.02	7.83	4.54	1.59	0.57	0.11	0.11	0.23	0.00
Keratocytes, donor1	11527-119I6	19.60	3.78	3.78	3.44	1.38	1.03	0.34	0.69	0.00	0.34
Keratocytes, donor2	11607-120I5	32.81	29.30	12.89	4.69	2.34	5.86	3.52	0.00	1.17	0.00
Keratocytes, donor3	11688-122I5	18.57	6.32	3.95	4.15	1.78	1.38	1.19	0.40	0.20	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	6.59	0.00	4.40	0.00	4.40	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	20.50	24.81	7.55	5.39	3.24	3.24	3.24	2.16	4.31	1.08
Lens Epithelial Cells, donor2	11609-120I7	24.10	17.99	18.11	7.04	4.50	4.38	3.81	1.96	1.27	0.35
Lens Epithelial Cells, donor3	11690-122I7	14.43	9.59	7.87	4.44	2.42	1.72	1.21	1.51	1.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	31.19	17.08	9.96	5.57	5.10	2.25	4.39	1.90	1.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	24.00	13.95	9.21	6.98	2.23	4.19	2.23	2.23	0.28	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	27.07	13.69	14.17	7.08	2.52	3.94	2.52	1.57	1.26	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	30.11	11.29	4.84	2.15	0.54	3.76	3.23	1.61	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	24.90	11.35	7.88	5.36	2.84	4.10	3.78	2.52	0.95	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	24.04	12.08	14.77	6.15	3.02	2.59	3.56	1.73	0.97	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	24.62	11.49	12.31	3.69	2.46	2.46	2.05	2.05	0.41	0.82
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	36.66	14.66	8.34	4.30	2.02	2.28	3.29	2.28	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	24.91	10.13	13.65	5.35	1.97	3.52	2.25	1.55	0.28	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	22.94	14.63	6.33	5.54	1.19	1.98	2.37	2.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	32.18	17.64	8.53	6.59	3.30	2.91	2.33	1.55	0.78	0.39
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	27.03	14.44	15.92	6.85	2.41	3.15	3.52	2.41	0.93	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	26.13	13.94	7.32	4.88	3.14	3.48	2.09	1.39	2.44	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	32.20	12.64	8.35	5.72	2.62	3.58	2.62	1.91	0.72	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	25.68	11.67	15.11	6.87	1.79	2.75	2.33	2.20	0.69	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	24.33	12.63	9.85	3.70	2.46	3.39	5.24	2.16	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	24.00	9.98	7.79	7.48	1.56	2.49	2.81	1.56	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	29.64	14.27	15.37	8.42	3.29	3.84	3.84	2.38	0.91	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	25.01	13.49	6.58	4.94	2.30	3.29	1.65	2.30	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	25.48	12.89	12.30	5.56	2.64	4.98	3.51	1.46	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	26.14	12.45	16.18	5.48	2.24	5.23	1.74	2.24	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	26.19	8.24	7.27	6.30	0.48	0.97	3.39	0.48	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	24.24	13.46	9.16	6.19	4.04	2.96	3.50	1.89	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	30.88	12.72	14.53	6.06	3.03	5.75	4.39	1.36	1.06	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	36.81	14.52	9.85	3.11	5.70	0.52	1.04	1.56	1.56	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	29.94	9.42	9.84	5.03	3.77	3.35	3.56	2.30	0.84	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	27.37	12.33	13.08	6.77	2.71	4.96	2.56	1.65	0.30	0.45
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	25.45	11.69	8.94	6.88	2.75	4.13	2.75	2.06	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	26.72	13.92	7.90	4.33	2.26	2.45	5.27	0.75	0.75	0.56
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	30.22	11.56	15.59	8.27	3.82	3.07	3.50	1.80	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	24.23	12.11	8.24	4.36	0.97	1.94	2.42	1.94	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	23.49	11.58	7.61	4.96	0.99	3.64	3.64	2.32	0.66	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	27.01	11.65	14.50	5.08	3.35	3.59	2.73	1.73	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	28.51	18.14	10.74	4.81	3.33	4.07	7.03	1.11	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	23.47	12.60	10.62	4.94	1.73	3.21	1.98	1.73	0.49	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	27.64	9.49	17.05	6.46	1.92	2.20	3.71	2.20	0.82	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	27.02	14.15	6.43	5.15	1.93	2.25	3.22	0.96	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	31.65	11.87	7.61	6.09	1.22	2.74	2.13	1.22	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	30.09	11.34	15.40	6.16	3.08	2.80	3.36	1.82	1.40	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	29.87	14.22	9.24	7.47	1.78	2.13	3.56	1.42	1.78	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	22.78	14.06	9.70	5.33	2.91	3.88	2.91	2.91	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	28.63	9.34	15.25	5.45	1.56	1.87	3.42	1.87	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	18.98	12.18	10.03	6.80	2.86	4.66	2.86	2.15	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	22.87	12.41	10.78	5.55	1.63	2.94	3.59	0.65	0.98	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	30.61	10.12	14.60	7.06	1.65	2.83	2.12	1.88	1.41	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	28.71	15.84	8.29	5.69	2.97	4.21	3.47	1.49	0.99	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	29.20	8.71	8.71	5.63	3.07	3.07	2.56	1.79	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	26.26	11.93	9.55	3.28	4.18	5.07	2.09	0.90	0.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	4.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	12.27	3.84	2.30	0.00	0.00	1.53	0.00	0.00	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	10.39	6.68	2.23	1.48	0.00	0.00	0.74	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	15.66	5.92	3.39	3.81	0.42	1.69	0.85	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	13.36	3.52	7.03	0.00	0.00	0.70	0.00	0.70	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	4.67	2.80	0.00	1.87	0.93	0.93	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.97	7.73	2.58	0.00	0.52	0.00	1.03	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	16.65	1.19	2.38	0.00	0.00	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	13.80	4.98	2.94	2.49	0.68	1.36	1.13	1.13	0.23	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	11.05	4.36	3.78	0.87	1.16	0.58	0.29	0.87	0.58	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	10.35	6.30	1.35	0.90	1.35	0.90	0.45	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	14.09	6.50	2.98	1.76	1.49	0.54	0.54	0.68	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	14.38	3.59	1.54	3.59	0.51	0.51	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	13.41	3.88	2.12	1.76	0.71	0.35	0.71	1.06	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.99	4.00	2.67	2.67	0.67	0.00	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	12.23	9.17	4.58	1.53	0.51	0.51	0.00	0.00	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	10.14	5.07	3.20	2.40	0.80	0.00	0.27	0.00	0.27	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.42	6.24	2.46	1.89	0.94	0.76	0.38	0.57	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	14.11	8.59	1.23	2.45	1.84	0.00	0.00	0.00	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	13.86	5.71	1.63	0.82	0.82	0.82	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	12.70	5.00	3.12	2.08	1.46	0.42	0.83	0.21	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	11.77	6.17	2.52	1.40	0.84	1.12	0.00	0.28	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	14.42	3.09	4.12	4.12	1.03	0.00	1.03	0.00	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	9.00	4.06	2.32	0.58	0.87	0.00	0.87	0.29	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	11.66	3.59	1.79	2.09	0.60	0.90	0.00	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	12.72	4.98	3.32	2.77	1.66	0.55	0.55	0.55	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	16.26	5.30	4.60	2.47	2.83	0.00	0.71	0.35	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	15.12	5.53	2.58	1.11	1.48	0.74	0.00	1.11	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	4.61	3.45	0.00	2.30	0.00	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	15.35	6.91	2.69	2.69	1.54	1.54	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	9.06	2.83	3.96	2.26	1.13	1.13	0.00	0.57	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	11.49	4.10	0.82	0.82	0.82	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	16.27	4.52	3.16	1.81	1.36	0.45	0.90	1.81	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	4.31	4.31	3.59	1.44	0.72	1.44	0.00	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.22	6.72	3.73	1.49	0.75	0.75	0.00	0.00	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	12.63	3.72	3.34	2.23	0.37	0.74	0.00	0.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	4.74	7.75	3.45	3.45	0.00	0.00	0.00	0.43	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	12.84	6.85	3.43	0.86	0.00	0.00	0.00	0.00	0.86	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	15.33	7.33	1.67	3.33	2.00	0.33	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	13.27	2.41	6.64	1.21	0.60	0.00	0.00	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	18.49	5.69	1.42	1.42	1.42	0.00	0.00	0.71	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	10.66	6.19	4.81	2.06	1.03	1.03	0.34	0.00	0.34	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	6.98	3.22	1.07	2.15	0.00	0.54	0.00	0.00	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	11.45	10.77	4.04	2.02	0.00	2.02	0.00	1.35	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	13.71	3.33	4.44	1.85	1.11	0.74	0.00	0.00	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	17.44	4.65	1.16	1.16	0.00	0.00	0.00	2.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	15.87	7.40	0.00	1.06	2.12	0.00	0.00	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	14.41	6.00	5.20	2.80	1.20	0.40	0.00	0.40	0.80	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	13.08	5.09	2.18	2.91	0.73	0.00	1.45	0.73	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	16.86	5.37	4.60	4.60	1.53	2.30	0.00	0.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	13.81	5.92	1.48	2.47	0.99	0.99	0.49	0.99	0.00	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	9.41	2.82	4.70	1.88	0.00	0.94	0.94	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	16.59	6.54	4.02	3.52	2.01	0.50	0.50	0.00	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	14.42	2.25	1.80	1.80	0.00	0.90	0.00	1.35	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	15.49	1.72	0.00	3.44	0.00	0.00	0.00	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	14.70	3.12	3.12	2.67	0.45	1.78	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	15.64	5.87	3.52	0.78	1.17	1.17	0.00	0.39	1.17	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	11.88	5.28	4.62	0.00	0.66	0.66	1.32	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	18.16	4.15	4.67	2.59	1.04	0.00	0.52	0.52	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	12.69	4.38	3.50	4.81	0.00	0.88	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	6.15	5.59	3.35	0.56	0.56	1.12	1.12	0.00	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	13.25	3.53	1.32	1.32	2.21	0.00	0.00	0.00	0.00	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	9.26	6.17	2.31	1.54	1.16	0.39	0.00	0.77	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	12.15	5.06	5.06	3.04	2.03	1.01	1.01	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	14.90	5.77	3.36	0.96	0.48	0.48	0.48	0.00	0.00	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	12.72	3.98	2.39	1.19	0.80	0.80	1.19	0.00	0.40	0.40
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	12.15	5.47	4.25	0.61	1.82	0.61	0.00	0.61	1.82	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	13.14	7.61	3.46	3.46	0.69	0.00	0.00	0.69	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	15.20	5.70	4.56	0.76	1.90	0.76	0.38	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	12.91	9.30	1.55	1.55	0.52	1.55	0.52	1.03	1.03	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	14.51	2.42	2.42	1.21	1.21	0.60	0.00	2.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	11.09	4.44	3.49	3.17	0.95	0.00	0.95	1.27	0.32	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	12.26	5.33	2.13	1.60	0.53	1.07	0.53	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	9.77	5.17	1.72	1.72	1.15	0.57	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	14.40	6.69	0.51	3.09	1.03	1.03	0.00	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.27	5.66	0.71	3.54	0.00	0.71	0.00	0.71	0.00	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.05	5.67	2.84	1.13	1.13	0.00	0.00	1.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	13.31	4.58	4.16	2.08	1.66	0.42	0.00	0.83	1.25	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	12.53	7.05	5.48	0.78	1.57	1.57	1.57	0.00	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	12.53	7.10	2.92	3.34	0.42	0.84	0.00	0.42	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	14.40	8.36	4.65	1.86	1.39	0.93	0.46	0.93	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	14.72	7.36	1.34	2.68	0.00	0.00	0.00	0.67	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	19.25	2.67	3.21	2.14	1.07	1.07	0.00	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	14.14	6.47	3.64	2.02	0.00	0.40	0.40	1.21	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	11.01	6.42	2.75	4.59	1.84	2.75	0.92	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.89	7.11	4.45	0.89	0.00	0.89	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	10.83	4.56	2.28	2.85	1.71	0.57	0.57	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	15.34	1.53	2.30	1.53	1.53	1.53	0.77	1.53	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.04	4.38	3.83	2.74	1.64	0.55	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	16.48	2.23	1.78	0.89	0.89	0.45	0.45	0.89	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	17.68	10.92	4.42	1.82	0.26	1.30	0.78	0.52	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.25	5.97	3.32	1.33	1.33	1.33	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	2.08	4.16	4.16	2.08	0.00	4.16	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	40.80	16.87	8.43	7.75	6.84	0.46	0.46	0.46	0.46	1.60
Macrophage - monocyte derived, donor2	11313-117C8	21.65	15.78	3.30	4.04	3.49	0.73	0.00	0.18	0.37	2.02
Macrophage - monocyte derived, donor3	11389-118C3	42.73	21.24	5.77	5.64	4.85	1.05	0.66	1.31	0.66	0.52
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	15.93	22.83	9.56	5.31	5.31	1.59	0.53	0.00	1.06	0.53
Mallassez-derived cells, donor2	11929-125I3	21.39	26.94	7.13	7.45	3.01	1.11	0.79	1.43	1.74	0.00
Mallassez-derived cells, donor3	11930-125I4	18.90	32.66	7.37	5.14	4.59	1.25	0.42	0.69	0.14	0.28
Mammary Epithelial Cell, donor1	11273-116H4	25.41	14.85	4.48	3.29	2.19	0.80	0.20	0.60	0.70	0.40
Mammary Epithelial Cell, donor2	11350-117G9	29.53	13.32	2.90	1.45	2.32	1.45	0.29	1.16	0.87	0.58
Mammary Epithelial Cell, donor3	11422-118F9	12.47	9.98	5.24	3.99	2.00	0.75	1.25	0.25	0.50	0.00
Mast cell - stimulated, donor1	11487-119E2	46.10	15.59	5.42	4.07	2.71	0.00	0.00	0.00	0.68	1.36
Mast cell, donor1	11563-120D6	96.35	30.60	10.92	6.27	4.00	1.19	1.19	0.65	0.97	3.14
Mast cell, donor2	11565-120D8	51.11	13.37	4.75	3.86	2.38	1.78	0.30	0.89	0.00	3.27
Mast cell, donor3	11566-120D9	61.91	14.63	11.93	4.73	5.18	1.80	1.80	1.80	1.35	3.60
Mast cell, donor4	11567-120E1	48.93	13.83	10.64	4.96	4.25	1.42	0.89	0.18	0.71	4.43
Mast cell, expanded and stimulated, donor5	11940-126A5	76.41	22.51	7.21	6.43	4.32	2.11	1.44	1.44	0.67	3.33
Mast cell, expanded and stimulated, donor8	11942-126A7	32.69	5.84	2.33	3.50	0.00	1.17	0.00	0.00	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	99.69	15.14	6.54	6.65	3.33	1.49	1.15	1.61	0.46	1.84
Mast cell, expanded, donor8	11941-126A6	53.89	11.72	11.72	5.02	1.51	1.34	0.84	1.00	0.00	2.01
Melanocyte - dark, donor1	11502-119F8	48.16	23.78	13.73	8.95	5.67	5.67	6.27	1.69	1.79	0.50
Melanocyte - dark, donor2	11582-120F7	32.53	26.65	8.65	5.88	5.19	4.50	3.46	3.46	3.11	0.35
Melanocyte - dark, donor3	11663-122F7	13.47	8.11	8.33	4.78	2.46	0.94	0.58	0.94	0.43	0.36
Melanocyte - light, donor1	11274-116H5	10.81	7.05	5.17	2.82	0.94	1.65	0.71	0.24	0.24	0.24
Melanocyte - light, donor2	11351-117H1	17.74	17.06	5.46	10.92	2.73	0.00	0.00	0.68	0.00	1.36
Melanocyte - light, donor3	11423-118G1	19.08	8.67	8.67	6.94	3.47	1.73	2.60	2.60	1.73	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	12.39	8.85	7.60	7.18	3.23	1.98	0.94	0.94	0.83	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	5.38	6.72	7.80	5.38	0.00	0.54	0.00	0.54	0.00	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	24.11	10.98	12.59	9.37	3.48	2.14	1.34	0.54	0.80	0.27
Meningeal Cells, donor1	11493-119E8	27.79	13.77	5.46	8.93	3.35	2.11	1.12	0.99	0.87	0.12
Meningeal Cells, donor2	11573-120E7	29.93	15.85	6.60	4.40	4.40	2.64	3.08	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	16.87	14.02	6.19	6.93	2.53	2.04	2.69	1.14	0.57	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	41.35	23.10	10.84	5.70	3.71	3.14	3.71	1.71	1.14	0.29
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	18.52	17.51	7.95	4.73	2.72	2.42	3.02	1.11	0.81	0.81
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	1.31	3.94	0.00	0.00	1.31	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	24.86	10.47	3.92	5.23	5.23	2.62	0.00	1.31	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	22.25	17.94	8.61	5.74	4.31	2.87	2.15	0.72	0.72	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	13.98	23.51	4.45	3.60	1.69	3.81	3.60	1.91	1.06	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	25.13	17.09	6.53	6.03	5.03	2.51	2.01	0.50	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	31.42	19.12	8.57	5.71	3.30	1.76	2.86	1.76	1.32	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	13.88	12.42	10.23	2.19	0.73	1.46	1.46	0.73	0.00	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	24.96	15.55	5.93	6.14	4.30	2.66	3.27	1.23	1.02	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	22.44	11.77	9.83	4.57	1.94	1.39	0.83	0.69	0.55	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	28.99	13.01	7.06	2.60	1.86	4.09	3.72	0.74	0.37	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	31.05	16.71	8.03	5.13	3.95	3.03	2.50	2.37	1.18	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	27.30	6.23	15.43	5.04	2.08	1.48	2.67	0.00	0.59	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	18.68	2.34	30.36	2.34	0.00	2.34	4.67	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	39.06	9.61	11.53	4.48	1.28	0.64	2.56	1.92	0.00	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	38.28	31.55	7.44	8.15	6.38	1.77	4.25	1.42	2.13	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	35.34	19.39	10.32	3.75	5.32	0.94	2.50	2.50	1.88	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	29.03	9.43	10.16	5.08	1.45	0.73	2.18	0.73	0.73	2.18
Mesothelial Cells, donor1	11247-116E5	15.11	58.87	7.42	5.57	3.45	3.18	6.89	2.65	0.27	0.80
Mesothelial Cells, donor2	12156-128G5	10.01	28.03	5.51	5.51	5.51	3.50	1.50	3.50	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	8.74	35.70	8.17	4.55	4.05	2.89	4.91	1.95	0.79	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	40.51	10.80	0.00	5.40	5.40	0.00	2.70	1.35	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	45.56	35.71	8.87	7.63	8.37	2.22	0.49	0.00	1.23	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	34.75	20.02	6.48	7.95	5.01	0.00	0.29	0.59	1.18	1.18
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	13.83	3.46	6.91	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	43.08	23.87	4.96	7.75	3.41	0.31	0.31	0.31	1.55	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	27.59	20.33	4.56	5.39	3.94	0.41	0.41	0.21	0.83	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	48.64	9.26	4.63	2.32	2.32	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	43.05	29.03	7.51	8.26	5.51	0.00	0.25	0.50	1.25	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	33.05	19.55	6.98	6.52	1.86	0.00	0.47	0.93	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	116.80	38.93	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	37.59	19.51	6.10	10.36	4.06	0.81	0.61	0.41	0.81	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	30.89	18.61	4.75	7.52	3.96	0.40	0.00	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	85.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	41.59	30.97	12.39	7.96	4.42	2.65	0.88	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	32.67	23.56	7.60	7.98	3.04	1.52	1.14	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	32.90	2.63	1.32	1.32	0.00	2.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	35.65	26.32	9.76	8.28	6.37	0.85	0.42	0.64	0.42	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	22.10	10.13	1.84	2.76	0.92	1.84	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	27.72	18.48	4.47	6.26	2.38	2.09	0.00	0.00	0.89	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	13.41	3.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	33.12	22.83	8.28	6.02	4.77	0.25	0.75	1.00	1.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	22.58	14.02	5.47	4.75	3.57	0.71	0.00	0.48	0.71	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	27.09	8.29	0.55	4.42	0.55	1.11	0.00	0.55	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	28.78	22.56	4.14	6.22	4.14	1.15	0.69	0.46	0.46	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	19.35	16.20	4.21	3.79	2.31	0.42	0.21	0.63	0.42	0.63
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	26.50	18.14	2.85	3.87	2.45	1.43	0.61	0.61	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	27.89	27.89	5.15	7.29	3.43	0.86	0.86	1.50	0.00	0.64
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	21.34	13.78	2.67	4.00	3.33	0.22	0.44	0.00	1.11	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	25.62	11.83	3.07	5.69	4.16	1.75	0.00	0.22	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	15.21	12.67	2.03	3.04	0.51	0.00	0.00	0.51	0.51	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	38.11	8.28	1.66	6.63	0.00	0.00	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	19.03	14.40	4.62	4.08	2.45	0.54	0.82	0.54	0.54	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	18.23	15.00	3.82	4.41	2.94	0.88	0.00	0.29	0.88	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	18.54	10.90	1.09	4.36	0.00	0.00	0.00	0.00	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.99	25.95	6.25	6.73	7.21	1.44	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	19.61	18.41	2.80	5.20	2.40	0.40	0.00	0.40	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	6.86	0.00	0.00	2.74	0.00	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	18.52	24.03	3.50	5.51	2.50	0.50	0.00	0.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	4.08	2.04	2.04	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	24.09	19.27	4.38	3.07	1.31	0.00	0.88	1.31	0.00	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	22.07	11.04	2.21	2.21	0.00	1.10	0.00	0.00	0.00	1.10
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	20.49	3.20	1.28	3.84	3.20	0.64	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	20.08	19.59	3.47	5.95	1.98	0.00	1.98	0.74	0.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	18.79	11.13	2.78	0.70	2.09	0.00	2.09	0.00	0.00	0.70
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	8.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	23.25	16.07	3.76	4.79	5.13	0.68	0.34	0.34	0.00	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	15.75	6.13	2.63	1.31	1.75	0.44	0.44	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	17.04	3.91	0.71	3.20	0.71	0.36	0.71	0.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	30.86	18.52	3.09	5.89	2.52	0.56	1.12	1.12	1.40	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.04	11.64	2.91	3.33	2.91	0.00	0.00	0.00	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	21.56	4.08	1.17	2.33	2.33	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	20.81	14.48	6.03	6.33	2.11	0.60	0.30	0.30	0.90	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	20.03	19.20	6.26	3.34	2.50	0.83	0.42	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	28.88	0.00	0.00	0.00	0.00	0.00	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	19.39	16.62	4.62	0.92	0.00	0.00	0.92	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	22.76	21.06	3.98	7.40	2.85	0.00	0.00	0.57	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	21.69	7.19	3.45	2.90	2.49	0.41	0.55	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	25.91	14.51	3.89	4.92	2.59	0.26	0.00	0.26	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	20.59	11.58	3.43	4.29	1.72	0.43	0.43	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	25.41	5.08	1.27	1.27	1.27	0.64	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	18.95	8.81	2.94	4.00	2.67	0.80	0.27	0.00	0.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	31.43	13.77	8.98	5.39	2.10	0.30	0.60	0.30	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	20.62	5.23	3.39	3.39	2.68	0.00	0.57	0.14	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	22.30	9.24	7.96	4.14	1.91	0.00	1.91	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	27.86	10.39	2.87	3.54	5.09	0.22	0.44	0.44	0.22	0.66
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	22.37	6.45	3.03	2.28	3.41	0.38	0.76	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	25.00	13.35	5.68	3.41	2.27	0.00	1.70	0.57	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	30.48	13.03	6.64	5.90	2.21	0.25	0.98	0.74	0.49	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	22.81	3.26	1.30	2.61	2.61	0.65	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	28.81	7.64	5.00	5.29	1.76	0.59	1.18	0.59	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	35.75	8.36	5.77	4.04	3.75	0.29	0.29	0.29	0.58	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	27.61	6.18	2.06	5.77	1.65	0.82	0.82	0.00	0.82	1.24
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	29.78	7.15	5.96	3.28	0.60	0.30	1.49	0.00	0.00	0.60
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	60.27	45.20	3.77	3.77	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	44.56	10.69	1.78	14.26	1.78	0.00	0.00	3.56	1.78	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	45.01	22.01	5.26	11.83	7.23	0.99	1.31	1.31	1.64	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	53.65	18.94	11.57	8.42	6.31	1.05	4.21	3.16	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	36.57	30.64	6.13	7.31	4.94	1.58	0.99	0.79	0.59	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	36.32	16.76	4.66	9.31	4.66	0.00	0.00	0.93	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	42.81	27.04	6.38	8.26	9.76	2.25	0.38	0.75	0.75	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	39.15	22.64	6.92	8.52	4.79	0.53	0.80	0.80	0.80	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	42.30	24.77	4.07	5.66	6.45	0.79	0.90	0.90	0.57	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	38.31	14.00	3.68	4.42	4.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	39.94	19.79	4.76	9.89	7.33	1.47	1.47	0.37	0.73	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	28.00	17.11	3.11	4.67	9.33	0.00	1.56	1.56	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	53.98	28.33	3.74	7.48	5.88	0.53	3.21	0.53	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	7.73	3.86	3.86	7.73	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	48.48	20.20	6.06	7.07	7.07	0.00	3.03	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	36.26	18.13	7.17	5.90	4.64	0.84	1.26	0.42	0.42	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	32.69	14.98	4.09	1.36	8.17	1.36	2.72	0.00	1.36	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	9.54	17.17	2.54	3.18	3.81	1.27	1.91	1.27	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	24.30	23.49	2.43	4.05	3.24	0.81	0.81	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	25.68	3.02	7.55	4.53	3.02	1.51	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	74.23	11.42	5.71	0.00	0.00	0.00	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	61.99	19.57	3.26	3.26	6.52	0.00	0.00	0.00	0.00	6.52
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	23.76	19.01	4.75	0.00	4.75	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	20.04	17.02	7.97	4.74	2.80	3.88	2.37	1.29	1.29	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	22.47	18.29	14.63	7.84	5.23	6.27	3.14	2.61	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	10.68	5.34	2.67	2.67	0.67	2.00	0.00	1.33	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	10.43	4.17	2.50	2.50	0.42	1.25	2.50	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	15.78	13.31	4.37	4.94	2.66	3.04	1.14	2.09	0.76	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	20.75	12.77	3.19	0.00	3.19	6.38	1.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	5.44	1.36	1.36	4.76	0.68	2.04	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	9.19	14.70	3.68	5.51	1.84	1.84	0.00	0.00	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	6.70	3.77	7.12	2.09	0.00	3.77	2.93	1.26	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	13.25	6.74	3.25	3.49	2.09	2.32	1.16	1.39	0.46	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	9.19	3.24	1.89	2.97	0.54	1.89	1.35	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	11.35	5.05	4.41	3.15	1.05	1.89	1.26	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	33.40	11.13	0.00	0.00	11.13	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	8.44	4.47	3.97	4.47	0.99	1.49	0.50	0.50	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	7.04	7.58	5.41	1.08	0.81	1.62	0.27	1.08	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	6.80	3.40	4.08	3.85	3.40	1.36	2.04	0.68	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.70	1.96	4.74	2.12	0.98	1.96	0.98	1.47	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	9.48	4.56	3.46	2.00	1.46	1.28	1.46	0.91	0.55	0.55
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	4.77	2.12	3.71	2.65	0.53	0.53	0.00	1.06	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	4.80	3.60	4.80	4.20	1.80	1.20	0.60	0.60	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	9.85	10.50	8.53	2.95	1.31	1.31	1.31	0.33	1.31	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	5.37	2.76	2.11	1.95	1.14	1.30	0.49	1.14	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	9.52	6.35	4.23	2.12	1.06	1.23	0.88	1.94	0.53	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	4.22	2.81	7.74	2.11	0.70	2.11	2.11	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	4.14	0.92	3.22	1.38	0.92	1.84	2.76	1.84	0.00	0.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	7.71	3.86	6.43	2.25	1.29	1.61	1.61	0.96	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	5.52	5.17	5.86	2.41	2.07	1.03	0.69	0.34	0.34	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	12.64	0.00	2.53	2.53	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	11.81	4.68	3.56	2.23	1.34	1.78	1.11	0.67	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	3.81	2.54	3.39	2.54	1.69	1.69	0.85	2.12	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	4.03	3.32	5.46	2.14	0.71	1.42	0.71	1.66	0.00	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	9.87	2.58	6.01	1.72	2.58	1.29	2.15	1.29	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	18.06	9.03	0.00	9.03	0.00	9.03	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	11.66	3.00	3.33	3.33	1.33	1.00	1.00	1.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.27	4.96	4.51	1.35	0.90	0.90	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	5.95	6.75	3.57	2.78	2.78	1.98	1.19	1.98	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	7.43	4.64	3.71	1.86	0.00	0.93	2.79	1.86	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	13.24	6.05	7.95	2.27	1.89	0.76	1.14	2.27	0.38	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	9.45	3.91	1.96	3.58	0.65	1.96	0.98	1.30	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	13.95	1.31	3.92	2.18	0.00	1.31	1.31	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	14.47	4.07	3.62	1.36	1.81	0.45	1.36	1.36	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	9.70	4.41	5.29	1.76	0.88	0.88	0.88	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	6.65	5.32	3.32	1.33	1.33	3.32	0.66	0.66	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	8.93	4.46	8.43	3.97	1.49	0.99	1.98	1.49	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	9.57	2.68	1.53	0.77	1.15	2.30	1.53	0.77	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	15.12	12.40	9.68	4.23	2.42	1.51	0.00	2.72	0.30	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	13.92	6.63	3.98	3.32	1.33	2.21	1.55	1.11	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	4.74	8.13	5.42	5.42	2.03	2.71	0.00	2.71	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	5.11	5.11	5.11	0.00	0.00	5.11	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	12.80	6.71	15.85	3.66	1.83	1.22	2.44	1.22	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	9.13	3.15	3.15	2.83	1.89	1.26	2.20	1.26	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	13.32	2.72	3.63	2.12	0.61	1.51	0.91	0.61	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	9.49	7.91	3.96	1.58	3.16	0.79	0.79	2.37	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	9.07	4.53	6.80	5.67	0.00	1.13	2.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	5.06	10.12	10.12	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	20.25	15.78	5.22	4.60	2.36	3.98	1.74	1.61	0.62	0.25
Myoblast, donor2	11322-117D8	17.84	11.51	4.79	4.99	3.07	4.60	1.92	3.26	0.38	1.15
Myoblast, donor3	11398-118D3	22.03	14.46	4.88	5.55	3.20	2.19	3.20	1.68	0.67	0.84
NK T cell leukemia cell line:KHYG-1	10777-110G3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	37.82	11.38	2.15	2.46	0.92	0.62	0.00	0.31	2.46	3.08
Natural Killer Cells, donor2	11311-117C6	23.52	7.84	3.62	1.21	1.81	0.30	0.00	0.00	0.90	3.32
Natural Killer Cells, donor3	11387-118C1	32.95	4.60	4.42	2.39	2.02	0.18	0.18	0.55	1.47	2.21
Neural stem cells, donor1	11275-116H6	17.42	14.52	6.53	4.36	2.18	6.17	2.18	5.44	0.73	0.00
Neural stem cells, donor2	11352-117H2	9.63	3.85	0.00	3.85	0.00	1.93	5.78	0.00	0.00	0.00
Neurons, donor1	11494-119E9	4.55	12.52	6.83	2.28	1.14	4.55	1.14	0.00	1.14	0.00
Neurons, donor2	11574-120E8	13.43	7.71	2.64	2.20	2.86	5.28	2.20	3.30	0.44	0.00
Neurons, donor3	11655-122E8	12.33	5.76	3.29	4.93	3.29	3.29	4.11	0.00	0.00	0.00
Neutrophils, donor1	11233-116C9	6.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	8.70	0.00	2.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	4.89	0.61	0.00	0.61	0.61	0.00	0.61	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	24.10	8.43	13.42	2.85	2.49	2.37	1.78	1.19	0.12	0.00
Nucleus Pulposus Cell, donor2	11409-118E5	24.42	6.19	13.02	3.91	1.95	2.93	3.58	2.93	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	19.05	6.62	8.82	4.61	1.60	2.01	1.00	1.00	0.20	0.20
Olfactory epithelial cells, donor1	11933-125I7	20.37	7.85	9.64	3.85	1.93	2.06	1.65	1.10	0.69	0.14
Olfactory epithelial cells, donor2	11934-125I8	22.44	12.01	10.71	5.07	1.74	3.04	1.45	1.01	0.58	0.14
Olfactory epithelial cells, donor3	11935-125I9	20.66	11.46	8.63	5.22	2.50	1.93	0.68	1.48	0.45	0.11
Olfactory epithelial cells, donor4	11936-126A1	28.25	7.89	5.55	5.16	1.95	1.46	0.97	1.46	0.39	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	24.07	18.66	7.82	8.43	3.01	1.81	1.20	1.20	1.20	0.60
Osteoblast - differentiated, donor1	11276-116H7	24.89	12.76	9.15	2.98	2.55	2.13	2.34	2.55	0.21	0.21
Osteoblast - differentiated, donor2	11353-117H3	10.29	12.57	10.29	5.72	4.57	4.57	4.57	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	19.24	5.59	9.31	2.48	3.10	3.72	1.86	2.48	0.00	0.00
Osteoblast, donor1	11277-116H8	25.41	18.18	7.62	9.77	6.06	4.30	2.74	3.91	1.17	0.00
Osteoblast, donor2	11354-117H4	13.34	10.53	5.62	3.51	1.40	2.11	2.11	0.70	1.40	0.00
Osteoblast, donor3	11426-118G4	18.66	10.31	8.53	4.09	3.55	3.73	3.20	1.96	0.89	0.00
Pancreatic stromal cells, donor1	11249-116E7	23.00	45.40	9.10	8.26	6.99	3.96	3.03	2.02	3.12	1.60
Pericytes, donor1	11491-119E6	18.47	4.23	5.45	2.67	1.11	1.67	1.34	0.33	0.33	0.00
Pericytes, donor2	11571-120E5	15.39	4.07	17.43	2.72	1.81	1.36	1.36	0.45	0.45	0.23
Pericytes, donor3	11652-122E5	29.91	21.36	8.34	8.95	5.70	3.46	4.27	1.63	1.42	0.61
Perineurial Cells, donor1	11499-119F5	22.15	16.39	9.15	6.78	4.52	1.70	1.92	1.24	1.70	0.57
Perineurial Cells, donor2	11579-120F4	34.32	29.81	9.11	8.28	5.70	4.78	5.80	2.85	1.84	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	45.26	6.06	3.51	2.23	3.19	1.27	0.32	0.32	0.00	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	24.98	3.18	4.90	2.69	0.98	1.22	0.00	0.24	0.73	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	34.94	4.92	3.24	3.75	0.91	0.52	0.13	0.13	0.78	0.91
Placental Epithelial Cells, donor1	11278-116H9	8.37	3.11	2.15	1.91	0.48	0.72	0.48	0.00	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	23.29	3.33	3.33	3.33	2.22	1.11	1.11	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	6.87	3.73	3.53	2.55	1.57	0.98	0.79	0.39	0.39	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	16.46	12.03	7.91	4.11	1.58	2.22	2.85	1.90	0.63	0.00
Preadipocyte - breast, donor1	11467-119B9	10.50	18.57	5.06	4.31	2.44	3.75	2.81	3.94	1.13	0.19
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	9.40	11.88	6.40	4.96	1.83	2.22	1.31	1.57	0.39	1.83
Preadipocyte - breast, donor2	11328-117E5	11.71	11.03	9.23	4.28	2.93	3.38	2.70	1.58	0.68	0.00
Preadipocyte - omental, donor1	11468-119C1	13.85	19.29	5.54	4.58	3.20	4.26	2.45	3.09	1.49	0.11
Preadipocyte - omental, donor2	11329-117E6	12.22	8.29	8.73	3.06	0.87	3.06	3.93	1.75	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	16.04	12.46	6.02	5.30	2.86	2.58	3.29	1.58	1.00	0.14
Preadipocyte - perirenal, donor1	11469-119C2	24.61	17.72	3.94	5.91	2.95	2.95	0.00	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	39.00	159.70	6.76	12.90	9.21	6.45	17.20	6.45	5.53	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	24.79	25.68	9.39	9.03	4.96	7.08	3.54	2.12	1.77	0.00
Preadipocyte - subcutaneous, donor3	11428-118G6	19.75	34.74	10.56	6.30	4.26	4.09	5.45	1.53	1.19	0.51
Preadipocyte - visceral, donor1	11280-116I2	29.71	35.40	7.17	7.82	4.75	4.10	4.84	3.35	1.02	0.47
Preadipocyte - visceral, donor2	11357-117H7	34.05	30.83	11.04	9.20	5.52	3.22	2.76	3.22	3.22	0.46
Preadipocyte - visceral, donor3	11429-118G7	24.45	27.27	6.48	7.84	4.49	3.45	3.45	2.19	2.19	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	8.60	10.11	2.56	2.41	1.36	1.06	0.91	0.30	1.06	0.15
Prostate Epithelial Cells, donor2	11331-117E8	9.21	17.20	4.60	4.47	2.17	0.81	0.95	0.54	1.35	0.41
Prostate Epithelial Cells, donor3	11404-118D9	7.23	4.29	4.78	2.82	2.33	0.49	0.18	0.67	0.31	0.31
Prostate Stromal Cells, donor1	11254-116F3	26.88	31.66	6.72	6.38	4.67	6.49	5.35	2.96	1.14	0.46
Prostate Stromal Cells, donor2	11332-117E9	23.67	14.34	5.92	3.59	2.51	3.94	3.94	2.15	2.15	0.36
Prostate Stromal Cells, donor3	11405-118E1	21.48	20.02	5.11	5.32	3.55	3.34	4.17	1.56	0.94	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	25.18	5.47	12.41	5.11	2.19	0.36	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	21.76	8.32	11.16	5.96	2.15	0.21	0.28	0.21	0.55	0.14
Renal Epithelial Cells, donor1	11517-119H5	22.32	6.59	9.64	3.55	0.00	0.51	1.01	0.51	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	27.03	4.98	9.96	5.69	4.27	1.42	0.71	2.13	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	30.28	8.79	16.41	6.56	2.75	1.06	0.42	0.42	1.16	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	29.28	23.15	17.70	10.89	1.36	2.72	2.72	0.68	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	34.90	29.78	15.77	11.59	5.93	3.64	2.02	1.08	0.67	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	30.86	19.31	10.21	5.77	4.44	2.66	3.55	1.78	1.33	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	17.97	9.98	6.65	3.99	2.00	2.00	5.99	3.33	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	34.99	12.99	7.92	3.30	1.98	2.64	1.76	1.54	0.22	0.88
Renal Mesangial Cells, donor2	11598-120H5	27.59	6.27	8.78	3.76	3.13	2.51	0.63	0.00	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	20.25	4.16	9.99	6.38	1.66	1.39	0.83	1.11	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	36.51	14.76	7.52	3.22	4.29	1.07	1.34	0.00	0.81	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	24.46	4.64	6.33	4.22	2.11	1.27	0.00	1.27	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	28.73	12.54	8.10	5.21	2.12	2.51	1.16	0.58	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	18.93	9.59	6.48	3.63	1.30	1.04	1.04	0.00	0.52	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	11.65	15.63	7.11	4.26	1.99	4.26	4.26	0.57	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	23.67	4.12	4.12	1.03	0.00	2.06	1.03	2.06	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	23.08	7.03	8.28	4.01	1.25	3.01	1.76	1.51	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	18.58	20.18	6.82	3.88	2.67	2.54	2.54	1.20	0.80	1.07
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	14.29	6.25	7.15	8.04	0.89	0.00	2.68	0.00	1.79	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	18.71	19.26	5.50	4.95	4.95	0.55	0.55	0.55	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	14.50	10.44	8.70	4.06	3.48	0.58	0.58	0.00	1.16	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	16.25	4.42	4.42	2.21	1.69	1.04	1.04	1.17	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	14.00	3.97	5.06	3.38	1.89	1.39	0.79	0.40	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	19.41	6.69	6.25	4.13	2.01	0.67	0.78	1.34	0.22	1.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	22.70	7.57	9.18	6.70	2.36	1.36	1.74	0.62	0.50	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	15.50	4.89	6.18	4.89	2.10	1.75	1.52	0.35	0.47	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	16.87	5.55	6.24	5.08	1.39	0.92	1.62	0.46	0.23	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	11.23	4.11	4.24	4.38	1.92	1.23	0.96	0.82	0.27	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	13.16	4.84	7.26	4.54	0.76	1.36	0.61	1.06	0.15	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	19.53	7.71	7.71	3.76	1.61	0.72	1.43	0.54	0.36	1.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	17.79	5.88	6.89	3.73	2.01	0.72	0.57	0.29	0.57	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	13.63	4.83	5.79	3.65	1.93	1.50	2.04	0.11	0.97	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	17.48	7.08	6.86	3.54	1.11	0.66	1.77	0.44	0.44	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	16.25	4.78	3.44	3.63	0.96	0.96	0.76	0.38	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	13.60	4.01	6.52	3.82	1.40	1.21	0.75	0.56	0.19	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	18.79	8.27	6.95	3.57	1.32	0.19	1.88	0.38	0.56	1.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	15.92	3.58	5.44	3.85	0.66	1.06	0.27	0.40	0.93	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	13.14	3.99	6.42	3.60	1.56	1.07	1.65	0.19	0.29	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	19.67	6.68	6.30	4.01	2.48	0.95	1.15	0.38	0.38	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	14.63	5.23	5.55	4.49	1.17	1.07	0.75	0.32	0.43	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	14.02	4.20	5.61	2.52	1.68	0.56	0.84	1.12	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	13.84	5.30	9.06	3.42	2.56	0.85	0.85	0.68	0.68	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	15.13	4.01	4.38	3.28	1.46	0.73	0.18	0.18	0.18	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	14.35	4.05	7.48	2.82	1.47	0.74	1.10	0.00	0.61	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	15.98	4.70	6.85	4.03	2.15	1.21	0.94	0.54	0.54	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	15.80	6.37	4.01	3.54	1.42	0.71	0.71	0.47	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	13.10	6.15	4.96	5.36	1.79	0.60	1.19	0.40	0.20	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	16.37	5.61	5.14	3.04	1.87	0.94	1.17	0.70	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	11.20	5.81	4.77	4.15	1.24	0.83	0.83	0.62	0.41	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	14.60	4.65	4.65	3.10	1.77	2.21	1.11	1.11	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	13.58	5.01	5.43	4.39	0.84	1.46	0.42	0.42	0.42	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	15.88	4.71	6.46	4.58	1.08	1.35	0.54	1.62	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	16.86	3.58	4.43	3.07	2.38	1.87	1.02	0.51	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	15.81	4.63	6.17	3.08	0.96	0.19	1.16	0.58	0.77	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	13.24	7.39	5.67	4.47	1.89	2.41	0.69	0.69	0.34	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	15.09	4.12	4.53	3.15	1.51	0.96	1.10	0.82	0.96	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	16.25	5.09	7.55	4.10	0.99	2.13	1.15	0.99	0.33	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	19.43	6.31	4.77	2.56	0.85	0.68	0.51	0.85	0.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	20.42	7.69	8.88	5.62	2.07	1.63	0.59	0.74	0.30	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	19.19	4.00	7.20	4.26	2.67	1.07	1.07	0.53	0.00	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	17.15	5.95	4.98	4.01	1.24	0.41	0.83	1.24	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	19.52	6.19	8.81	5.24	1.67	1.19	1.19	0.48	1.19	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	19.55	11.29	5.84	6.25	1.21	1.01	1.41	0.20	0.40	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	18.65	9.32	9.32	4.14	2.26	0.75	0.85	0.75	0.66	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	22.01	8.38	10.83	3.84	1.40	2.10	1.40	0.70	1.40	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	13.60	9.67	6.65	3.02	2.72	0.91	1.21	0.60	0.60	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	21.17	13.58	11.01	4.53	2.81	0.98	0.49	0.49	0.73	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	23.00	22.12	9.61	6.84	5.68	2.47	2.33	1.31	2.47	2.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	21.29	17.04	7.91	3.65	4.26	3.04	1.22	1.83	3.04	1.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	18.99	14.17	9.95	6.03	4.82	1.51	1.21	0.00	1.51	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	16.74	11.08	9.73	5.43	3.39	2.71	1.13	1.36	1.13	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	19.77	15.58	8.39	7.19	2.10	1.50	2.40	0.60	2.70	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	19.48	13.93	6.97	5.31	3.42	2.13	0.71	0.71	1.18	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	19.21	16.01	8.32	7.04	3.84	0.64	2.13	0.85	1.92	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	24.04	14.42	16.23	3.61	6.01	0.60	3.61	0.60	2.40	1.80
Schwann Cells, donor1	11498-119F4	28.02	9.78	13.54	6.58	2.44	2.26	1.50	0.75	0.00	0.00
Schwann Cells, donor2	11578-120F3	13.61	20.41	10.21	6.80	0.00	3.40	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	14.90	11.17	11.17	8.11	1.75	2.41	1.31	1.75	0.22	0.22
Sebocyte, donor1	11220-116B5	18.62	11.50	8.76	4.93	2.74	0.00	0.00	0.55	0.00	0.00
Sebocyte, donor2	11301-117B5	8.27	5.06	3.22	5.51	0.92	0.46	0.00	0.46	1.38	0.00
Sebocyte, donor3	11378-118B1	8.24	5.57	7.21	2.06	2.68	0.41	0.41	0.21	0.00	0.21
Sertoli Cells, donor1	11255-116F4	14.91	48.04	4.97	9.94	4.97	4.97	1.66	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	19.77	33.89	11.30	2.82	5.65	2.82	2.82	2.82	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	20.50	11.26	10.12	4.22	2.73	4.40	4.31	2.55	0.70	0.18
Skeletal Muscle Cells, donor2	11358-117H8	15.90	27.47	11.57	5.78	5.78	7.23	5.06	5.06	1.45	0.00
Skeletal Muscle Cells, donor3	11430-118G8	21.74	17.56	16.72	6.69	7.52	4.18	4.18	1.67	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	16.81	13.51	6.44	6.44	2.36	2.20	2.04	2.36	0.63	0.31
Skeletal Muscle Cells, donor5	11455-119A6	16.65	8.77	7.58	5.20	2.82	2.38	1.04	0.89	0.45	0.15
Skeletal Muscle Cells, donor6	11459-119B1	21.55	11.54	8.77	5.85	0.46	1.69	2.00	0.92	0.15	0.62
Skeletal Muscle Satellite Cells, donor1	11240-116D7	28.35	14.87	13.99	7.31	3.78	3.02	1.76	1.39	1.26	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	22.12	12.56	16.55	5.42	3.28	2.43	2.14	0.57	0.43	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	17.86	14.39	8.33	5.65	4.07	2.28	1.98	1.88	1.19	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	12.97	19.80	10.28	7.16	2.61	4.63	5.14	4.04	0.84	0.08
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	15.20	9.41	10.13	3.62	3.62	4.34	3.62	0.72	4.34	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	13.35	8.39	7.02	5.50	2.48	3.03	2.06	2.75	0.41	0.00
Skin - palm, donor1	10286-104F7	37.61	0.00	2.69	0.00	0.00	2.69	5.37	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	9.80	11.39	3.89	3.03	2.02	1.15	0.58	0.43	0.43	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	27.81	47.44	4.09	1.64	1.64	0.82	0.00	0.00	4.09	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	8.83	10.00	1.56	1.69	1.17	0.91	0.13	0.78	0.78	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	19.32	24.19	6.67	3.48	4.87	0.70	0.42	0.42	1.11	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	16.03	11.25	4.22	3.52	2.25	1.55	0.98	0.56	1.97	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	22.20	25.80	4.44	3.17	3.59	0.42	0.21	0.85	5.71	6.13
Small Airway Epithelial Cells, donor3	11406-118E2	10.64	10.87	4.42	3.30	1.95	0.75	0.52	0.15	0.67	0.07
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	22.53	25.00	4.63	6.17	2.78	3.70	1.54	1.54	1.23	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	10.89	14.45	3.11	4.45	1.78	3.33	1.11	0.89	1.56	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	29.39	17.05	2.94	8.23	4.70	2.94	2.35	0.59	2.94	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	19.67	14.59	2.87	6.41	2.87	1.99	0.88	0.88	0.44	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	31.50	28.75	4.33	6.69	2.36	4.33	3.54	3.54	0.79	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	33.22	17.00	9.27	8.50	2.32	3.86	3.09	0.77	2.32	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	33.02	31.02	32.02	8.01	2.00	1.00	13.01	2.00	1.00	2.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	32.34	20.49	12.64	7.19	3.86	3.73	2.79	2.26	1.73	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	24.38	19.06	7.98	5.98	2.66	2.66	2.44	2.22	1.77	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	36.10	40.46	9.60	6.53	3.71	6.02	5.76	2.94	1.41	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	19.54	14.00	9.44	4.88	2.93	1.30	1.63	0.98	0.65	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	13.58	12.11	8.86	5.02	3.84	1.77	2.36	1.77	0.89	1.18
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	18.08	9.40	6.69	5.55	3.70	2.56	1.85	1.42	0.71	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	19.85	6.51	6.83	2.93	1.46	1.46	0.33	0.98	0.49	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	21.31	7.61	12.79	3.65	3.65	2.44	2.44	0.91	0.91	0.30
Smooth Muscle Cells - Carotid, donor1	11285-116I7	23.74	24.25	10.10	7.32	4.80	3.54	4.04	2.27	1.26	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	6.12	6.12	6.12	6.12	0.00	6.12	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	29.09	22.41	10.49	7.63	6.20	5.25	2.38	1.43	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	20.94	10.03	6.93	3.54	2.80	1.18	0.88	1.18	1.03	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	20.23	10.55	4.95	2.80	2.58	3.44	2.37	1.29	0.65	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	17.95	12.07	7.87	5.14	3.67	1.78	1.47	1.68	0.52	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	31.86	31.25	6.81	6.50	4.02	4.33	3.56	2.63	0.77	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	32.34	45.27	7.55	8.62	8.62	5.39	5.39	4.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	17.63	8.97	5.38	3.59	4.48	2.39	1.20	1.79	1.20	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	21.85	7.51	6.49	2.73	1.37	1.71	1.37	0.34	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	29.37	11.70	18.06	4.95	2.98	1.10	1.81	1.02	1.02	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	21.13	26.47	8.05	5.23	2.82	4.83	5.03	3.02	1.71	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	28.44	20.93	5.01	6.14	2.28	4.78	4.78	2.05	1.82	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	28.98	20.53	8.45	8.45	1.81	4.23	1.81	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	17.75	13.25	2.91	5.83	3.71	1.85	2.12	0.53	0.79	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	27.70	28.50	7.99	5.59	4.26	2.93	4.39	1.73	1.86	1.60
Smooth Muscle Cells - Prostate, donor2	11335-117F3	19.03	11.27	5.26	2.50	3.13	4.63	4.01	2.50	1.13	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	11.92	17.00	11.67	6.09	2.79	2.79	2.54	1.78	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	30.46	32.27	10.10	8.14	4.98	3.92	4.67	3.77	2.11	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	26.26	23.26	15.75	8.25	3.75	4.50	3.75	2.25	1.50	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	20.68	6.46	10.34	3.88	0.00	2.58	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	26.97	46.04	8.37	10.70	4.65	4.19	3.26	3.26	3.26	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	19.69	18.68	9.59	7.57	3.03	6.06	4.04	2.02	2.02	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	25.70	32.91	8.15	8.15	3.45	2.51	1.57	2.51	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	15.34	9.44	14.16	4.42	2.36	1.18	1.77	0.88	0.59	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	28.49	18.58	14.50	6.66	3.75	2.83	2.83	1.17	0.83	0.33
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	14.48	7.94	19.62	5.14	1.87	1.87	0.93	1.40	0.93	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	28.21	25.33	8.49	6.48	5.47	3.74	3.60	2.01	0.86	0.43
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	23.46	14.02	10.45	6.88	4.59	3.31	1.53	0.76	1.02	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	27.64	16.17	10.15	8.09	4.14	2.26	0.94	0.94	1.13	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	24.60	15.51	9.78	6.29	3.63	1.68	1.12	0.56	0.84	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	29.07	11.73	12.07	6.79	4.52	1.84	2.09	1.09	0.67	0.00
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	6.19	1.90	6.67	1.43	0.00	0.95	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	32.54	20.06	9.30	6.36	2.69	3.91	3.43	0.98	1.47	0.73
Smooth Muscle Cells - Uterine, donor1	11258-116F7	21.21	30.49	8.84	4.42	2.65	1.99	3.09	1.99	2.65	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	21.07	16.68	4.68	4.97	3.80	1.46	2.93	0.59	1.76	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.91	10.50	9.72	2.53	1.55	3.11	0.97	2.14	0.39	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	13.22	10.31	1.85	2.91	2.12	2.64	1.06	2.12	0.53	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	23.06	57.28	5.95	7.44	4.84	3.35	1.12	1.86	1.49	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	24.08	24.43	13.30	3.59	5.39	1.08	1.08	3.23	2.52	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	20.16	11.36	4.26	2.84	0.28	1.70	0.85	1.14	0.57	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	22.45	26.78	1.97	7.48	5.12	6.30	2.36	1.18	1.58	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	24.38	29.71	6.09	3.81	1.52	1.52	2.54	1.02	2.29	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	34.74	13.58	10.78	1.60	3.99	0.80	2.80	0.80	0.40	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	18.81	15.88	7.52	3.34	0.84	5.02	2.09	0.84	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	23.38	29.79	9.63	4.58	5.04	6.88	5.04	5.04	0.46	0.00
Synoviocyte, donor1	11291-117A4	20.87	12.79	11.78	6.23	2.86	4.38	2.36	1.85	1.35	0.34
Synoviocyte, donor2	11368-117I9	12.74	10.06	15.09	4.69	3.35	3.69	3.18	2.01	0.50	0.00
Synoviocyte, donor3	11440-118H9	18.99	10.05	8.27	5.81	2.90	4.02	1.34	2.23	0.89	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	42.52	11.43	10.36	7.15	1.07	2.50	2.86	1.43	0.36	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	21.80	0.00	15.86	0.00	0.00	1.98	1.98	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	18.99	7.18	7.64	6.71	0.93	3.01	3.24	1.16	0.23	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	17.56	9.61	6.24	4.73	2.80	0.29	0.22	0.29	0.57	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	17.78	15.85	7.34	5.03	2.71	1.55	0.77	0.00	1.55	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	15.46	17.18	6.87	5.73	1.72	1.15	0.57	1.15	1.72	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	17.96	19.68	6.89	4.43	3.44	2.34	2.09	0.98	1.72	1.48
Urethra, donor2	10319-105A4	43.16	8.99	5.40	3.60	1.80	3.60	0.00	5.40	0.00	0.00
Urothelial Cells, donor1	11520-119H8	18.06	9.56	7.17	3.98	1.33	0.80	0.27	0.80	0.00	0.00
Urothelial Cells, donor2	11600-120H7	16.42	7.21	8.01	7.21	0.80	0.00	0.00	0.00	0.40	0.00
Urothelial Cells, donor3	11681-122H7	11.69	5.96	6.88	5.50	2.75	0.46	0.23	0.46	0.00	0.00
Urothelial cells, donor0	11216-116B1	22.74	7.80	9.14	6.91	4.46	0.22	0.00	0.00	0.22	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	41.82	12.46	8.01	4.45	0.89	0.89	0.00	0.89	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	50.04	7.15	7.15	5.72	2.86	1.43	0.00	0.00	4.29	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	30.80	2.05	3.42	1.37	2.74	0.00	1.37	0.68	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	34.09	6.89	2.75	4.48	2.41	0.00	0.00	1.03	0.34	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	41.25	5.81	5.23	2.32	2.32	2.32	0.58	2.32	0.58	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	36.44	4.16	6.25	1.04	4.16	0.00	0.00	0.00	2.08	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	33.96	14.68	8.26	3.67	4.59	0.00	0.00	0.92	1.84	2.75
Whole blood (ribopure), donor090612, donation3	12184-129A6	36.52	8.22	3.65	7.30	2.74	0.91	0.00	2.74	0.91	3.65
Wilms' tumor cell line:G-401	10809-111A8	34.66	8.51	1.97	2.34	2.59	0.74	1.11	0.62	0.62	0.62
Wilms' tumor cell line:HFWT	10597-108E3	32.56	2.64	7.04	0.00	0.00	2.64	2.64	2.64	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	25.70	17.88	10.33	8.38	3.63	1.68	0.28	0.28	1.68	0.56
achilles tendon, donor2	10292-104G4	20.67	4.13	6.20	2.07	2.07	0.00	2.07	4.13	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	9.52	2.09	1.16	1.16	0.46	0.00	0.00	0.00	0.23	0.46
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	61.28	9.84	6.46	6.18	2.53	0.28	0.00	0.28	0.28	2.53
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	65.56	8.46	3.81	3.17	1.48	0.42	1.69	0.21	0.85	1.27
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	27.77	10.34	6.81	3.54	2.18	0.82	0.54	0.82	1.36	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	77.11	25.12	7.93	6.61	4.41	0.44	0.88	2.20	0.88	1.32
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	40.84	7.76	5.31	2.86	3.27	1.63	0.41	0.82	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	3.50	0.18	0.55	0.55	0.00	0.00	0.00	0.00	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	41.36	14.18	6.51	4.18	3.95	0.23	0.46	0.93	0.70	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	7.31	0.58	0.88	1.17	0.88	0.00	0.29	0.29	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	29.28	3.25	4.65	3.25	0.93	0.00	0.00	0.46	1.39	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	7.98	0.61	0.92	0.92	0.00	0.00	0.00	0.31	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	10.24	0.00	0.43	2.13	0.85	0.43	0.00	0.00	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	7.89	0.91	0.91	1.21	0.00	0.00	0.00	0.00	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	10.11	2.17	1.44	2.17	0.48	0.24	0.24	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	27.84	15.81	5.57	5.35	2.00	0.45	0.67	0.22	0.67	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	4.00	0.00	2.00	0.00	1.00	0.33	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	37.16	9.29	3.72	1.86	1.86	1.86	1.86	0.00	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	60.64	16.57	6.40	5.65	4.90	0.75	1.51	1.88	1.51	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	71.96	21.37	7.41	4.80	4.36	1.74	3.05	0.87	1.31	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	39.36	0.00	0.00	0.00	3.75	0.00	0.00	0.00	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	19.31	32.03	21.67	13.42	10.60	3.77	2.12	1.18	1.18	0.24
adipose tissue, adult, pool1	10010-101C1	26.06	15.36	9.00	3.57	3.41	3.26	0.78	2.79	0.78	1.09
adipose, donor1	10184-103D4	13.49	2.93	1.17	0.00	0.59	0.00	0.00	0.00	0.00	0.00
adipose, donor2	10185-103D5	6.08	1.22	2.84	1.22	0.41	0.00	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	5.72	1.91	1.63	1.09	0.82	0.00	0.54	1.63	0.82	0.00
adipose, donor4	10187-103D7	6.93	5.20	1.73	2.60	0.87	0.00	0.00	0.87	0.87	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	19.89	3.63	10.26	1.42	1.42	0.79	1.10	0.32	0.00	0.32
adrenal gland, adult, pool1	10081-102A9	36.38	25.46	29.10	0.00	3.64	7.28	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	17.51	3.22	3.93	4.64	1.43	0.00	0.71	0.71	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	7.42	9.74	4.41	4.41	2.55	0.93	0.23	0.23	1.16	0.70
amniotic membrane cells, donor2	12236-129G4	13.86	3.38	2.37	2.03	1.01	0.34	0.00	0.00	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	5.01	2.95	1.47	0.59	0.88	0.29	0.00	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	14.23	2.37	0.00	2.37	1.19	0.00	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	22.91	13.59	5.27	4.46	2.64	2.84	1.01	1.62	0.81	3.24
amygdala, newborn, donor10223	10360-105E9	4.84	13.88	2.26	2.90	0.97	1.94	0.97	0.00	0.65	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	39.73	12.35	16.04	6.88	4.71	1.53	2.16	1.02	1.66	0.38
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	7.68	3.01	4.01	2.00	1.67	0.33	0.67	0.00	0.00	1.00
aorta, adult, pool1	10052-101G7	28.44	10.98	12.75	6.67	3.53	4.12	2.55	0.59	1.37	0.98
appendix, adult	10189-103D9	26.39	14.75	8.93	6.99	5.05	2.72	2.33	0.78	0.00	2.72
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	33.71	11.01	3.78	3.10	1.38	0.34	0.00	0.00	0.69	1.03
artery, adult	10190-103E1	59.78	9.51	8.15	8.15	4.08	8.15	1.36	9.51	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	50.27	28.10	9.13	13.18	7.10	6.66	11.30	3.62	1.16	1.30
b cell line:RPMI1788	10427-106D4	2.08	0.00	0.30	0.30	0.00	0.00	0.00	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	36.07	39.40	12.49	11.93	7.21	2.50	3.88	1.11	2.22	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	30.27	18.06	4.27	4.17	2.98	1.49	2.58	0.69	0.99	0.60
bile duct carcinoma cell line:TFK-1	10496-107C1	14.39	2.34	1.51	1.84	0.00	0.67	0.00	0.17	0.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	59.28	4.47	7.83	4.47	1.12	1.12	1.12	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	32.38	9.78	10.54	4.24	2.82	3.48	0.98	1.96	0.65	1.85
blood, adult, pool1	10053-101G8	37.65	2.21	4.43	0.00	2.21	0.00	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	18.84	15.41	4.28	3.43	0.86	0.00	0.86	0.00	0.00	0.86
bone marrow, adult	10192-103E3	22.27	14.85	4.72	2.02	3.37	1.35	1.35	0.67	0.00	0.67
brain, adult, donor1	10084-102B3	20.50	5.13	2.05	1.03	3.08	1.03	1.03	1.03	0.00	1.03
brain, adult, pool1	10012-101C3	28.62	6.90	4.12	2.45	1.67	1.56	0.89	1.00	0.45	1.56
brain, fetal, pool1	10085-102B4	2.67	5.34	8.01	2.67	0.00	8.01	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	30.06	7.60	8.59	2.64	1.32	1.32	0.99	0.66	1.65	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	33.20	10.98	2.75	3.87	1.87	1.00	0.37	1.00	0.75	0.75
breast, adult, donor1	10080-102A8	15.78	10.73	7.58	8.84	5.05	1.89	1.89	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	6.22	5.46	2.79	1.02	0.64	0.00	0.13	0.00	0.13	0.51
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	19.79	4.02	2.47	2.47	0.93	0.31	0.31	0.31	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	34.99	21.87	14.04	9.90	4.60	1.15	0.69	0.46	0.46	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	12.59	8.96	2.66	3.63	2.66	0.48	0.00	0.00	1.21	0.24
carcinoid cell line:NCI-H1770	10703-109H1	6.58	3.29	1.41	1.88	0.00	0.94	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	21.88	13.56	5.14	1.86	2.95	0.55	0.44	0.22	0.98	0.44
carcinoid cell line:SK-PN-DW	10719-109I8	1.27	2.85	0.00	0.95	0.63	0.00	0.32	0.32	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	9.05	12.24	9.05	3.99	1.33	2.66	1.33	0.27	0.53	1.86
caudate nucleus - adult, donor10196	10177-103C6	21.88	13.82	3.45	4.61	1.15	2.30	2.30	3.45	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	19.74	14.56	7.53	4.85	2.01	1.67	1.67	1.00	0.50	2.68
caudate nucleus, adult, donor10258	10379-105H1	24.45	14.52	5.35	1.53	2.29	2.29	0.76	0.00	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	7.69	10.99	4.39	3.30	1.83	1.10	2.93	1.83	0.73	0.00
cerebellum - adult, donor10196	10173-103C2	34.96	8.74	8.74	2.91	0.00	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	15.37	8.97	6.41	4.48	4.06	2.14	1.71	2.14	2.35	5.55
cerebellum, adult, pool1	10083-102B2	21.73	3.10	4.83	1.03	1.38	1.38	0.69	2.41	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	7.47	11.62	1.66	3.32	2.49	1.66	1.66	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	21.94	5.55	4.54	1.51	2.77	1.26	1.76	0.76	1.26	0.00
cerebrospinal fluid, donor2	10294-104G6	37.28	7.31	1.46	1.46	0.00	1.46	0.00	2.19	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	139.04	13.80	9.20	6.76	5.32	5.46	4.31	5.18	0.14	1.15
cervical cancer cell line:ME-180	10553-107I4	11.93	3.65	2.49	3.31	0.99	0.66	0.66	0.00	0.99	0.33
cervix, adult, pool1	10013-101C4	28.77	22.26	10.18	6.51	4.09	5.88	3.46	3.15	1.36	2.62
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	31.91	7.94	8.08	3.62	1.53	2.93	3.34	2.09	0.84	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	19.59	0.00	9.14	0.00	1.31	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	31.79	8.87	9.36	4.68	1.72	0.74	0.25	0.12	0.49	1.36
choriocarcinoma cell line:T3M-3	10618-108G6	2.61	0.47	0.24	0.24	0.47	0.00	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	8.26	60.69	14.25	14.25	6.27	1.42	1.14	0.85	3.42	0.57
chorionic membrane cells, donor2	12239-129G7	17.40	53.10	6.96	12.33	7.36	1.89	1.69	0.99	1.09	0.99
chorionic membrane cells, donor3	12240-129G8	18.68	101.11	21.43	23.63	9.34	2.75	2.20	2.75	3.85	2.20
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	39.76	7.88	6.53	3.84	1.92	0.00	1.15	0.19	0.58	0.38
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	26.61	2.53	1.69	1.90	0.63	0.21	0.42	0.63	0.21	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	44.17	20.54	11.04	6.42	3.85	4.88	1.54	2.05	0.77	2.05
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	56.60	22.98	11.13	9.68	4.11	3.39	2.42	3.39	1.21	2.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	41.94	19.75	8.76	8.76	2.44	4.68	4.28	2.04	0.61	3.26
chronic myelogenous leukemia cell line:K562	10454-106G4	35.04	14.72	7.95	12.96	3.83	2.36	1.77	1.47	0.59	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	47.17	10.69	5.47	5.73	2.61	2.35	5.99	3.39	0.00	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	47.54	6.40	10.06	4.34	2.51	0.00	0.00	0.00	0.00	0.23
clear cell carcinoma cell line:TEN	10636-108I6	9.89	6.07	2.08	2.26	1.21	0.69	0.35	0.17	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	11.17	6.22	2.93	2.38	1.46	0.00	0.18	0.18	0.18	0.55
colon carcinoma cell line:COLO-320	10420-106C6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	21.42	22.61	28.56	24.99	5.95	3.57	2.38	0.00	0.00	1.19
colon, adult, pool1	10014-101C5	25.85	38.89	19.15	12.81	7.87	4.23	2.94	2.35	1.65	1.29
colon, fetal, donor1	10070-101I7	17.30	21.01	20.39	11.74	6.80	3.09	3.09	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	155.84	41.25	13.75	18.33	9.17	9.17	0.00	0.00	9.17	0.00
common myeloid progenitor CMP, donor2	12134-128E1	150.22	25.04	0.00	0.00	0.00	0.00	25.04	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	47.59	13.60	1.27	1.27	0.85	0.85	2.55	1.70	0.42	1.70
cord blood derived cell line:COBL-a 24h infection	10453-106G3	57.81	12.38	1.96	2.41	1.51	1.36	1.21	0.45	0.15	1.51
cord blood derived cell line:COBL-a untreated	10449-106F8	65.99	15.37	1.97	2.96	0.85	0.99	1.27	0.28	0.42	1.27
corpus callosum, adult, pool1	10042-101F6	60.48	15.04	10.61	5.20	4.75	5.09	3.43	3.21	0.88	4.75
cruciate ligament, donor2	10295-104G7	23.50	8.92	5.67	2.43	0.81	2.43	1.62	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	21.67	12.84	10.43	4.01	3.21	8.83	0.80	0.80	1.61	0.80
diencephalon, adult	10193-103E4	28.32	7.44	4.32	3.12	1.68	0.96	1.92	2.64	0.72	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	14.36	4.87	3.59	1.80	1.03	0.26	0.26	0.00	0.51	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	33.46	39.72	6.74	5.30	5.54	2.89	3.61	1.69	1.20	2.17
ductus deferens, adult	10196-103E7	38.37	19.93	9.97	6.48	5.48	5.98	1.50	4.98	2.49	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	20.16	36.01	30.24	18.72	8.64	5.76	0.00	0.00	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	22.81	38.25	19.86	8.09	5.89	5.15	2.21	2.94	2.21	0.74
dura mater, adult, donor1	10041-101F5	35.93	9.33	7.85	3.55	2.23	2.23	1.57	0.99	1.07	4.96
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	16.88	9.99	3.78	3.78	2.89	1.33	1.78	0.44	2.22	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	18.05	16.91	8.45	8.60	1.43	3.01	4.01	1.86	0.86	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	29.60	3.70	1.23	1.85	1.23	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	33.30	4.54	6.66	3.94	1.51	1.51	1.82	0.00	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	28.71	4.63	3.70	1.54	2.78	0.31	0.62	0.31	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	45.97	5.25	3.94	0.00	1.31	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	61.68	6.37	4.02	1.34	0.67	1.34	0.34	0.00	0.34	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	41.87	5.80	10.87	5.80	3.08	1.99	1.27	2.54	0.18	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	7.88	1.61	2.89	2.57	0.96	0.80	0.48	0.32	0.16	0.00
epidermoid carcinoma cell line:A431	10426-106D3	22.68	23.57	5.56	5.45	5.11	1.45	1.22	0.56	1.00	0.56
epidermoid carcinoma cell line:Ca Ski	10431-106D8	38.38	20.57	7.59	8.25	4.29	1.76	2.86	0.77	0.99	1.43
epididymis, adult	10197-103E8	31.40	12.56	7.12	5.02	3.98	4.40	2.72	3.98	1.05	1.05
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	43.47	9.58	5.85	4.79	1.95	3.02	3.02	1.95	0.53	1.42
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	14.55	2.36	2.75	0.79	0.39	2.36	0.79	0.79	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	35.38	34.20	8.13	7.34	7.08	6.29	7.47	3.28	3.01	2.49
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	35.63	31.49	7.28	8.17	5.91	5.02	4.92	2.07	2.07	1.38
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	35.18	35.29	7.95	9.07	11.43	4.37	4.93	2.24	3.02	2.13
esophagus, adult, pool1	10015-101C6	23.15	21.24	8.71	7.75	4.88	4.46	2.02	1.91	0.96	0.85
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	18.03	27.80	9.02	4.76	5.01	8.02	5.13	7.89	4.51	1.00
eye - muscle inferior rectus, donor1	10272-104E2	50.71	0.00	7.24	4.83	0.00	0.00	2.41	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	69.44	6.31	6.31	2.10	2.10	4.21	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	81.85	1.49	4.46	0.00	0.00	1.49	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	56.18	2.29	8.03	4.59	2.29	4.59	3.44	4.59	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	62.67	2.91	4.37	0.00	1.46	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	26.44	22.88	12.71	3.31	4.32	2.80	4.83	3.31	3.05	1.53
fibrosarcoma cell line:HT-1080	10758-110E2	20.13	5.90	9.23	4.74	1.15	0.64	0.51	0.51	0.38	0.51
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	29.44	12.58	10.21	5.70	3.56	0.95	1.42	0.24	0.95	0.24
frontal lobe, adult, pool1	10040-101F4	22.99	7.22	3.75	2.06	1.31	1.50	1.22	1.13	0.84	2.63
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	30.02	9.91	4.20	4.20	1.50	1.50	0.60	0.30	0.00	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	66.38	7.77	10.79	7.13	4.02	1.65	0.82	1.01	0.55	0.55
gall bladder, adult	10198-103E9	29.21	29.45	8.93	7.24	4.10	6.76	2.41	3.38	2.41	0.48
gamma delta positive T cells, donor1	11937-126A2	55.30	10.74	6.44	5.37	3.76	0.54	0.54	0.54	1.61	2.15
gamma delta positive T cells, donor2	11938-126A3	51.54	14.57	7.47	2.99	2.61	0.00	0.00	0.00	4.48	1.87
gastric adenocarcinoma cell line:MKN1	10614-108G2	12.88	21.76	3.38	5.49	2.96	1.27	2.32	0.84	1.48	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	28.24	21.66	12.77	6.58	5.03	2.51	4.45	0.58	0.97	1.93
gastric cancer cell line:AZ521	10549-107H9	45.42	9.51	7.38	3.77	2.46	0.82	2.13	0.49	0.33	1.15
gastric cancer cell line:GSS	10560-108A2	47.59	11.90	25.63	6.41	0.92	0.92	0.00	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	22.62	15.31	4.11	3.20	1.60	0.00	0.46	0.23	1.83	0.23
giant cell carcinoma cell line:LU65	10487-107B1	15.60	4.02	6.20	5.85	0.92	1.72	1.03	0.57	0.57	0.46
giant cell carcinoma cell line:Lu99B	10433-106E1	57.80	18.19	20.43	9.38	4.34	3.36	3.08	0.98	0.56	1.26
glassy cell carcinoma cell line:HOKUG	10688-109F4	19.95	5.24	2.00	1.00	2.24	2.74	0.25	0.50	1.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	21.85	11.82	5.07	3.48	1.27	0.95	0.95	1.37	1.06	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	20.64	10.25	4.92	3.65	2.81	0.14	0.70	0.84	0.56	0.14
glioblastoma cell line:T98G	10485-107A8	42.16	18.32	5.63	6.84	4.08	1.66	1.99	0.88	1.43	0.77
glioma cell line:GI-1	10413-106B8	16.99	9.96	7.61	2.93	0.88	2.05	1.46	0.88	0.29	0.88
globus pallidus - adult, donor10196	10175-103C4	45.19	9.48	10.20	2.92	0.73	5.83	0.73	1.46	0.73	0.00
globus pallidus, adult, donor10252	10161-103A8	56.87	30.76	12.20	8.54	6.35	4.64	2.69	2.44	2.93	7.81
globus pallidus, adult, donor10258	10367-105F7	56.14	10.95	2.74	2.74	1.37	0.00	1.37	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	15.45	15.99	3.73	3.20	2.66	2.13	4.26	3.20	2.13	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	190.88	12.24	9.79	7.34	0.00	0.00	2.45	4.89	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	185.78	10.93	10.93	0.00	21.86	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	130.66	15.68	0.00	0.00	0.00	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	12.80	6.08	4.48	6.40	1.60	1.92	0.96	0.32	0.64	0.32
hIPS +CCl2, biol_rep1	14383-156B9	11.48	3.67	0.92	0.46	0.00	0.00	0.00	0.00	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	12.80	1.37	0.00	1.37	0.91	0.00	0.00	0.91	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	8.37	3.86	1.29	0.64	0.00	0.00	0.64	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	10.06	0.00	0.00	1.44	1.44	0.00	0.00	0.00	5.75	0.00
hIPS, biol_rep2	14381-156B7	14.40	6.17	0.69	0.00	0.00	0.00	0.00	0.00	0.69	0.69
hIPS, biol_rep3	14382-156B8	28.69	3.31	3.31	0.00	1.10	0.00	0.00	0.00	2.21	0.00
hairy cell leukemia cell line:Mo	10712-109I1	0.57	0.00	0.00	0.57	0.00	0.00	0.00	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	43.65	21.23	8.97	6.88	3.89	5.68	4.19	1.79	1.49	1.20
heart - pulmonic valve, adult	10206-103F8	49.42	13.34	7.84	6.28	4.97	6.54	3.14	3.40	1.05	0.78
heart - tricuspid valve, adult	10207-103F9	20.82	10.82	6.66	6.66	1.67	7.49	3.33	0.83	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	35.51	14.90	14.49	7.96	6.33	5.51	2.65	1.22	1.02	0.82
heart, adult, diseased, donor1	10051-101G6	49.40	19.16	19.16	15.76	8.52	15.33	14.90	3.41	2.13	0.00
heart, adult, pool1	10016-101C7	58.41	15.87	15.18	11.27	3.68	11.27	8.28	7.36	0.46	0.00
heart, fetal, pool1	10046-101G1	32.45	9.75	9.34	4.93	2.57	5.34	3.80	1.64	1.23	0.51
hepatic mesenchymal tumor cell line:LI90	10778-110G4	30.85	14.19	9.56	7.71	1.54	2.47	3.09	1.54	1.23	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	10.28	5.08	4.09	3.43	1.88	0.33	0.44	0.22	0.88	0.55
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	8.86	4.01	4.85	3.40	0.97	0.36	0.61	0.12	0.61	0.49
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	10.51	5.36	5.15	2.73	1.92	0.51	0.61	0.30	0.61	1.01
hepatoma cell line:Li-7	10484-107A7	37.81	11.12	3.89	6.45	3.34	2.22	2.67	1.78	1.11	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	18.93	5.68	3.79	4.73	0.95	0.00	1.89	1.89	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	25.31	17.76	8.57	3.67	3.47	3.67	2.25	1.84	1.63	3.06
hippocampus, adult, donor10258	10374-105G5	21.91	7.97	1.99	2.49	0.00	1.49	0.50	0.50	0.50	0.00
hippocampus, newborn, donor10223	10363-105F3	4.58	6.70	3.52	1.06	1.06	1.76	1.41	2.47	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	19.53	15.87	2.44	1.83	1.83	0.00	1.22	0.00	0.61	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	9.43	3.93	4.12	2.36	0.59	0.39	0.00	0.39	1.18	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	10.92	4.82	3.55	0.25	0.25	0.00	0.51	0.25	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	3.38	0.56	0.56	0.00	0.56	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	5.94	0.00	0.00	0.26	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	5.69	1.14	1.14	0.00	0.00	0.00	0.00	0.38	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	4.38	1.46	1.46	0.88	0.29	0.00	0.00	0.29	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	4.31	1.29	1.29	0.65	0.43	0.43	0.00	0.00	0.43	0.43
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	2.50	1.25	2.92	0.00	0.00	1.25	0.00	0.00	0.42	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	6.39	4.26	2.84	2.60	1.66	0.24	0.95	0.24	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	7.88	5.30	3.70	1.61	0.80	0.80	0.80	0.48	0.16	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	6.06	6.06	4.04	2.69	0.67	0.00	1.35	0.67	1.35	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	11.74	4.38	1.25	1.25	0.31	0.31	0.47	0.00	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	11.79	5.40	1.47	1.97	0.49	0.49	0.00	0.00	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	20.07	3.49	4.36	0.00	0.87	0.87	0.87	0.00	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	9.55	2.48	1.34	0.76	0.38	0.00	0.00	0.00	0.19	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	7.41	0.87	0.00	0.00	0.44	0.00	0.00	0.00	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	11.99	4.00	1.00	0.50	0.00	0.50	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	6.78	2.45	3.58	0.38	0.75	0.38	0.00	0.19	0.00	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	5.91	1.36	6.37	0.45	1.36	0.45	0.00	0.45	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	5.64	1.57	2.51	0.63	0.63	0.00	0.00	0.00	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	6.21	2.45	3.59	1.63	1.14	0.82	0.82	1.14	0.65	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	6.97	2.61	4.35	1.45	0.29	0.29	1.16	0.29	0.29	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	4.78	2.39	2.39	0.90	0.90	0.90	0.90	1.20	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	10.35	7.39	2.59	1.85	1.11	0.18	0.00	0.37	0.00	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	13.41	6.85	2.00	0.86	0.86	0.29	0.57	0.86	0.57	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	17.15	6.53	4.90	1.22	1.22	1.22	0.41	0.82	2.45	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	12.32	4.22	0.35	0.70	1.06	0.00	0.00	0.00	1.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	12.67	2.53	0.63	1.90	0.95	0.32	0.00	0.00	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	14.53	2.42	0.91	0.61	0.30	0.00	0.30	0.00	0.00	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	9.31	3.62	5.17	1.55	0.52	0.00	0.00	0.52	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	9.30	4.65	1.99	1.99	0.66	2.66	0.66	0.00	1.33	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	9.24	4.36	3.08	1.80	0.00	0.26	0.51	0.51	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	8.44	6.39	2.30	3.83	0.77	0.26	1.53	0.00	0.77	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	12.12	8.33	3.03	1.51	1.51	0.76	2.27	0.76	0.76	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	7.06	6.05	4.37	2.02	2.35	1.01	1.01	0.34	0.34	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	10.87	4.83	1.93	1.21	1.21	0.48	0.48	0.00	0.97	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	10.25	7.13	0.89	0.89	1.34	0.00	0.89	0.45	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	12.68	6.83	3.41	0.98	1.46	0.98	0.49	0.00	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	14.67	1.22	0.61	0.31	0.00	0.00	0.00	0.31	1.22	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	45.55	13.01	0.00	6.51	6.51	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	11.58	2.65	0.33	0.66	0.66	0.00	0.00	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	9.30	6.02	2.74	0.55	1.09	0.55	0.00	0.55	0.55	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	10.13	6.15	2.90	1.09	1.81	0.00	0.36	1.09	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	6.05	3.20	1.78	1.42	1.07	0.00	0.36	0.00	0.00	1.07
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	7.16	3.58	0.00	2.39	1.19	2.39	0.00	0.00	2.39	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	7.72	5.69	2.71	2.30	1.35	0.95	0.54	0.95	1.08	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	6.73	2.42	2.96	1.35	0.54	0.81	0.54	0.27	0.27	0.00
immature langerhans cells, donor1	11904-125F5	8.48	2.66	2.66	0.48	0.24	0.00	0.24	0.00	0.24	0.24
immature langerhans cells, donor2	11905-125F6	11.09	1.58	0.79	0.79	1.58	0.79	0.79	1.58	0.00	0.00
insula, adult, pool1	10039-101F3	23.37	7.95	3.60	2.27	1.51	1.04	1.42	1.80	0.85	2.18
keratoacanthoma cell line:HKA-1	10791-110H8	0.33	0.65	0.65	0.33	0.00	0.00	0.00	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	23.73	23.83	6.31	6.21	5.61	2.40	3.20	1.40	2.10	1.30
kidney, fetal, pool1	10045-101F9	12.38	13.58	8.21	5.02	2.62	2.19	1.98	1.77	1.27	0.71
large cell lung carcinoma cell line:IA-LM	10509-107D5	64.34	9.94	12.21	5.54	3.55	1.28	3.55	0.43	0.85	1.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	27.37	9.82	9.95	3.18	1.38	0.41	1.52	0.41	0.41	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	28.44	7.16	7.34	5.87	2.39	0.92	0.37	0.55	0.37	0.37
left atrium, adult, donor1	10079-102A7	38.68	9.26	14.71	8.17	3.81	3.27	3.27	3.27	0.00	0.00
left ventricle, adult, donor1	10078-102A6	56.13	8.60	22.25	11.12	6.57	11.63	8.60	4.55	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	41.59	8.76	1.37	2.46	1.64	3.28	1.09	1.09	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	15.09	16.88	2.87	2.51	3.59	5.75	1.80	1.08	2.51	0.00
leiomyoma cell line:15242A	10570-108B3	17.93	41.30	6.52	3.26	1.63	3.26	4.89	0.54	1.63	0.00
leiomyoma cell line:15425	10571-108B4	17.00	20.64	5.10	3.16	2.43	1.70	0.97	3.40	0.49	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	12.70	0.00	0.00	0.00	19.05	0.00	6.35	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	20.91	9.41	8.36	8.36	1.05	9.41	1.05	2.09	3.14	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	33.88	7.79	7.08	4.96	3.54	2.24	1.89	1.06	1.42	0.59
liposarcoma cell line:KMLS-1	10782-110G8	15.78	5.62	8.90	3.12	0.94	0.94	0.78	0.62	0.31	0.47
liposarcoma cell line:SW 872	10726-110A6	46.18	43.01	12.67	11.70	13.04	7.55	9.63	3.29	3.17	0.97
liver, adult, pool1	10018-101C9	17.18	7.94	3.40	2.59	2.11	0.97	0.97	0.65	0.16	0.16
liver, fetal, pool1	10086-102B5	9.41	3.76	8.47	0.94	2.82	0.00	1.88	0.94	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	28.58	7.58	4.23	3.50	2.19	1.60	1.31	0.73	0.73	1.60
locus coeruleus, adult, donor10252	10165-103B3	31.37	21.04	9.04	4.98	4.06	3.32	3.51	1.85	1.11	5.54
locus coeruleus, adult, donor10258	10375-105G6	39.50	11.57	3.39	0.85	2.54	3.95	4.23	2.82	0.56	0.85
locus coeruleus, newborn, donor10223	10362-105F2	14.30	21.03	7.15	1.26	2.52	2.52	2.52	1.26	1.68	0.00
lung adenocarcinoma cell line:A549	10499-107C4	30.31	5.95	4.15	1.25	0.69	0.55	0.83	0.28	0.28	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	31.02	15.86	4.83	1.38	5.52	0.69	0.69	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	39.81	6.59	6.85	3.43	1.71	0.79	0.26	0.40	0.79	0.13
lung, adult, pool1	10019-101D1	31.78	25.87	7.44	4.96	3.43	3.19	4.96	1.42	1.65	1.30
lung, fetal, donor1	10068-101I5	33.68	49.09	16.27	5.42	5.71	7.71	5.71	6.28	6.28	0.86
lung, right lower lobe, adult, donor1	10075-102A3	31.62	25.66	6.42	8.25	9.62	1.83	4.58	3.67	1.83	0.92
lymph node, adult, donor1	10077-102A5	44.97	9.47	8.99	4.73	1.89	3.79	2.37	2.84	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	16.45	1.96	0.91	1.06	0.45	0.00	0.00	0.00	0.15	0.30
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	19.54	10.19	2.55	3.40	0.85	3.40	3.40	0.85	1.70	3.40
mature adipocyte, donor1	12231-129F8	47.95	12.43	7.99	2.22	2.66	6.22	1.33	6.66	0.44	0.44
mature adipocyte, donor2	12232-129F9	52.50	13.49	7.89	6.02	3.94	7.26	1.45	4.98	2.49	0.21
mature adipocyte, donor3	12233-129G1	44.57	14.22	11.62	6.64	2.84	4.50	2.37	7.11	0.47	0.71
mature adipocyte, donor4	12234-129G2	52.64	24.48	12.37	5.53	5.53	8.16	3.16	5.79	0.79	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	28.83	16.20	7.62	5.72	5.00	1.43	2.86	1.19	3.10	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	23.69	5.64	1.13	1.13	2.26	1.13	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	19.49	13.24	6.25	3.31	3.13	2.39	1.29	0.92	1.10	3.49
medial frontal gyrus, adult, donor10258	10368-105F8	18.43	6.04	4.13	0.32	1.27	0.95	0.95	0.32	0.32	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	7.25	11.52	3.41	3.41	0.00	2.13	0.85	0.00	0.43	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	15.36	5.06	2.36	1.35	1.35	1.01	0.68	0.51	0.00	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	22.28	14.22	7.43	3.18	2.55	1.91	1.91	0.85	0.85	4.46
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	19.26	0.00	1.93	0.00	0.00	1.93	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	14.35	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	3.23	8.26	1.08	0.72	0.00	0.72	0.36	0.36	0.00	0.36
medulla oblongata - adult, donor10196	10174-103C3	35.04	15.58	4.54	2.60	1.30	4.54	1.95	0.65	1.30	0.00
medulla oblongata, adult, donor10252	10155-103A2	31.58	16.25	6.97	6.50	4.64	3.41	3.41	1.39	1.08	4.33
medulla oblongata, adult, pool1	10038-101F2	47.10	13.96	6.78	3.51	2.37	2.29	2.53	1.55	1.39	4.00
medulla oblongata, newborn, donor10223	10361-105F1	15.62	20.14	6.25	3.47	2.43	11.80	9.72	2.78	0.69	0.69
medulloblastoma cell line:D283 Med	10838-111E1	0.00	0.00	0.00	0.00	0.22	0.00	0.00	0.22	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	5.87	1.83	2.45	1.47	0.73	0.37	0.37	0.12	0.12	0.12
melanoma cell line:COLO 679	10514-107E1	3.59	11.79	4.74	5.03	2.59	2.16	2.30	2.01	1.29	0.29
melanoma cell line:G-361	10465-106H6	9.23	5.97	10.32	5.97	2.71	0.27	0.54	0.27	0.81	0.54
meningioma cell line:HKBMM	10691-109F7	31.30	19.54	11.94	8.50	5.61	3.08	2.17	1.63	0.90	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	26.24	42.96	11.20	10.59	5.37	5.06	4.91	1.84	2.61	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	17.27	20.36	8.73	7.82	3.27	2.73	3.82	1.82	1.09	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	16.15	33.13	7.87	8.70	2.07	3.73	2.48	2.90	1.24	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	19.25	9.41	3.23	4.64	2.67	2.11	0.28	1.83	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	15.60	8.86	5.97	5.78	1.93	2.50	1.54	0.39	0.19	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	21.52	13.88	4.16	5.55	2.08	3.47	2.08	1.39	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	21.28	10.98	6.69	5.15	4.81	2.57	1.54	1.72	0.51	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	12.08	10.70	6.10	4.95	1.61	3.22	1.84	1.38	0.46	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	19.50	18.17	4.64	7.43	3.71	2.52	1.46	1.59	1.33	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	21.07	9.99	5.00	6.75	2.57	1.76	0.54	1.62	0.81	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	17.64	15.93	6.54	6.26	2.56	1.71	0.85	1.85	1.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	18.44	3.95	8.23	3.29	0.99	0.99	0.99	0.66	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	20.20	18.40	8.99	9.27	3.04	2.49	1.52	0.69	2.63	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	31.07	36.30	10.82	11.17	4.19	2.79	2.09	1.05	1.75	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	23.89	19.40	16.13	7.96	4.49	1.84	1.02	0.82	0.61	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.38	15.46	8.63	4.31	3.95	1.08	0.72	0.00	1.08	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	12.31	7.14	7.76	4.45	2.38	0.93	1.45	0.62	0.52	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	16.64	71.13	5.24	6.38	5.47	3.88	3.88	1.82	1.37	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	28.95	35.66	13.01	10.07	5.45	0.84	3.78	2.94	1.26	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	15.54	13.60	8.07	8.37	2.54	1.20	1.05	1.64	1.49	0.45
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	19.34	19.08	7.35	8.14	3.59	2.01	1.40	2.19	0.88	0.18
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	13.99	12.15	13.99	7.73	2.58	1.84	0.00	0.00	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	18.89	18.31	7.15	6.30	2.00	2.00	0.29	0.57	0.57	0.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	35.37	20.21	10.53	9.68	5.47	4.21	0.42	2.53	2.11	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	22.38	21.92	10.05	7.76	5.02	7.31	4.57	4.11	1.83	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	15.86	23.02	13.81	6.14	4.09	6.91	4.86	2.30	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	17.28	18.85	12.30	7.07	3.93	4.45	4.19	2.62	1.31	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	18.18	19.72	11.71	6.16	2.77	7.39	5.55	3.70	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	19.53	23.77	13.89	6.35	4.24	5.41	4.71	2.82	0.71	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	17.26	19.29	18.95	6.09	2.37	7.11	5.75	4.40	1.35	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	12.58	24.36	14.15	7.47	5.89	8.25	2.36	6.29	1.96	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	17.61	27.34	17.61	6.95	1.39	2.78	3.24	1.85	2.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	17.59	28.84	12.69	6.92	2.88	5.77	4.61	3.46	2.31	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	17.18	22.76	11.38	5.13	3.12	4.91	6.92	2.68	0.89	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	14.90	24.28	16.34	5.29	2.88	3.85	5.29	5.05	1.20	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	12.47	16.87	14.67	6.60	3.67	3.67	2.93	2.93	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	16.11	16.78	14.43	5.71	3.36	4.70	8.73	5.03	0.67	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.05	24.97	10.23	8.60	3.68	4.50	3.28	3.28	0.41	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	20.19	20.62	10.74	7.30	1.29	5.58	4.30	3.01	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	27.34	30.08	21.88	16.41	5.47	2.73	2.73	2.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	25.82	15.49	5.16	10.33	5.16	0.00	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	21.76	25.66	14.29	6.17	4.55	6.17	6.17	3.25	0.65	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	10.18	30.55	27.64	4.36	5.82	10.18	2.91	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	17.06	26.65	21.32	9.60	3.20	6.93	5.33	2.67	1.07	0.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	15.54	20.44	12.27	4.09	3.27	0.82	5.72	5.72	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	13.61	23.32	13.99	4.28	3.89	5.44	4.66	1.55	0.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	14.69	10.49	2.10	6.30	6.30	4.20	4.20	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	10.93	15.90	14.90	4.97	3.97	3.97	7.95	0.99	1.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	14.30	4.77	9.53	4.77	4.77	9.53	0.00	4.77	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	14.23	24.90	15.42	2.37	4.15	5.34	3.56	2.96	1.19	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	25.59	18.28	12.18	3.66	2.44	9.75	7.31	2.44	3.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.73	27.24	13.30	5.07	2.53	3.17	3.17	1.27	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	23.45	10.69	15.87	2.41	3.10	2.76	2.41	1.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	15.04	2.15	17.19	2.15	4.30	2.15	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	3.99	3.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	24.11	6.89	13.78	3.44	0.00	0.00	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	19.97	8.15	14.26	2.04	1.63	2.44	0.81	0.81	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	26.22	12.71	12.71	0.00	1.59	1.59	3.18	1.59	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	23.58	7.07	13.56	1.77	1.18	1.18	0.59	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	22.44	6.55	13.71	2.18	1.56	1.87	1.25	2.49	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	22.72	2.67	16.04	2.67	0.00	5.35	4.01	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	16.56	10.64	9.46	3.55	2.37	2.37	1.18	1.18	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	15.41	10.27	7.70	7.70	0.00	0.00	0.00	5.14	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	17.90	6.88	8.95	4.13	3.44	2.75	0.69	2.75	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	15.34	57.89	9.90	4.95	4.45	17.81	13.36	6.43	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	15.70	59.44	14.58	3.36	3.36	11.22	11.22	7.85	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	21.63	61.70	11.45	7.00	7.00	10.18	12.09	3.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	26.19	141.45	14.91	9.27	9.67	20.55	24.58	9.27	2.01	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	21.81	133.02	13.08	6.54	4.36	26.17	17.44	8.72	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	19.01	126.71	6.34	7.60	7.60	22.81	29.14	5.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	10.92	30.34	7.89	4.25	6.07	9.71	6.68	6.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	31.63	40.67	13.56	4.52	9.04	18.08	9.04	18.08	0.00	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	24.71	32.95	9.06	5.77	1.65	10.71	8.24	4.94	1.65	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	15.87	38.49	10.72	3.97	1.98	6.75	5.75	3.17	0.99	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	13.63	28.56	12.98	4.87	2.92	9.73	7.14	1.95	0.32	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	17.32	29.54	14.26	1.02	1.02	2.04	10.19	2.04	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.21	4.64	0.77	6.19	0.77	1.55	2.32	0.77	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	38.27	9.69	11.58	4.72	3.07	1.18	1.89	0.71	0.00	1.18
mesothelioma cell line:ACC-MESO-4	10494-107B8	19.00	9.96	3.94	3.24	0.46	0.70	0.00	0.46	0.46	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	8.55	17.09	4.27	8.55	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	17.47	10.79	6.27	6.06	2.57	1.75	1.54	0.21	0.72	0.10
mesothelioma cell line:Mero-25	10850-111F4	22.24	9.76	4.31	2.95	2.04	0.68	0.45	0.45	1.36	0.45
mesothelioma cell line:Mero-41	10851-111F5	32.52	35.94	10.76	8.07	7.09	5.13	3.42	2.44	1.96	0.24
mesothelioma cell line:Mero-48a	10852-111F6	15.50	23.69	7.31	4.43	3.99	2.66	2.21	1.55	0.22	0.66
mesothelioma cell line:Mero-82	10853-111F7	15.77	24.44	6.31	6.04	4.20	4.20	3.68	1.58	1.31	1.05
mesothelioma cell line:Mero-83	10854-111F8	20.43	9.02	4.26	4.26	2.89	2.89	2.72	1.19	0.68	1.19
mesothelioma cell line:Mero-84	10855-111F9	5.06	5.81	2.27	1.77	0.51	0.25	0.25	0.00	0.00	0.00
mesothelioma cell line:Mero-95	10856-111G1	14.70	14.29	10.56	3.52	2.07	3.31	0.41	1.66	0.83	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	16.07	20.71	5.63	2.65	1.66	1.66	1.49	0.50	1.16	0.00
mesothelioma cell line:NCI-H226	10846-111E9	22.08	18.46	4.52	3.98	1.09	1.99	1.45	0.72	0.72	0.54
mesothelioma cell line:NCI-H2452	10848-111F2	33.48	33.48	8.03	6.83	4.95	3.76	2.73	2.73	2.05	1.54
mesothelioma cell line:NCI-H28	10845-111E8	19.59	11.20	9.42	3.82	0.76	0.00	0.51	0.25	0.00	1.02
mesothelioma cell line:No36	10857-111G2	53.82	16.31	8.16	4.24	1.63	2.61	0.98	1.96	0.98	0.33
mesothelioma cell line:ONE58	10858-111G3	36.31	29.80	6.23	6.23	3.52	2.17	2.44	1.35	1.35	0.27
migratory langerhans cells, donor1	11901-125F2	29.17	7.68	8.06	5.57	2.11	0.00	0.19	0.38	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	29.31	9.40	7.94	5.50	1.83	0.24	0.49	0.49	0.24	0.24
migratory langerhans cells, donor3	11903-125F4	53.84	12.56	7.72	4.49	2.15	0.18	0.54	0.00	0.36	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	52.89	15.02	16.32	11.10	7.18	3.59	3.59	1.63	1.31	1.63
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	32.85	6.57	9.75	5.93	5.51	2.76	4.45	1.27	1.70	0.21
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	41.46	9.44	5.76	4.61	3.46	0.69	0.92	0.92	0.46	0.46
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	28.16	4.38	0.76	1.71	0.76	0.19	0.00	0.19	0.19	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	2.59	0.55	0.37	0.18	0.00	0.00	0.00	0.00	0.00	0.00
myeloma cell line:PCM6	10474-106I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	29.93	8.12	6.09	3.55	1.52	2.03	0.51	0.00	1.52	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	32.76	9.81	4.32	4.51	2.35	3.14	2.94	0.98	0.98	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	9.25	5.46	5.68	3.01	2.23	0.78	0.22	0.56	0.22	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.44	5.88	4.49	3.68	1.32	0.51	0.15	0.66	0.44	0.29
nasal epithelial cells, donor2	12227-129F4	9.94	4.42	6.07	3.86	1.66	0.55	0.55	0.55	0.55	0.55
neuroblastoma cell line:CHP-134	10508-107D4	6.21	2.30	5.52	2.30	0.92	0.69	0.00	1.15	0.23	0.92
neuroblastoma cell line:NB-1	10539-107G8	23.76	6.36	3.37	3.55	2.06	1.31	0.19	0.56	0.37	0.94
neuroblastoma cell line:NBsusSR	10607-108F4	7.80	4.01	2.74	3.37	0.63	1.69	1.05	0.63	0.42	0.42
neuroblastoma cell line:NH-12	10555-107I6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.71	6.41	1.42	1.19	1.66	1.90	0.47	1.90	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	6.97	12.04	3.64	5.07	5.07	6.02	0.48	3.80	0.95	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	1.41	1.21	1.61	0.20	0.40	0.40	0.40	0.20	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.00	0.00	3.81	0.64	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	24.49	23.95	8.52	6.12	6.12	3.46	7.19	2.93	1.86	0.27
neutrophil PMN, donor1	12133-128D9	223.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	104.18	0.00	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	49.04	4.06	4.06	2.03	0.34	0.17	0.00	0.34	0.17	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	13.61	6.40	3.20	0.00	1.60	1.60	0.00	0.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	22.76	23.72	17.63	7.37	5.77	3.53	4.17	1.92	0.64	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	52.29	48.87	7.36	11.30	7.62	3.68	4.20	1.31	2.89	0.00
nucleus accumbens, adult, pool1	10037-101F1	23.62	8.44	3.37	2.34	1.87	1.22	1.22	1.22	0.94	2.62
occipital cortex - adult, donor10196	10172-103C1	18.54	0.00	2.06	6.18	2.06	0.00	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	26.30	16.37	9.66	4.56	4.56	1.34	3.76	0.54	1.61	5.64
occipital cortex, newborn, donor10223	10355-105E4	4.37	4.00	2.18	1.46	0.36	2.55	1.09	1.09	1.46	0.36
occipital lobe, adult, donor1	10076-102A4	23.09	7.08	3.41	1.57	2.10	1.05	0.52	0.79	0.00	0.52
occipital lobe, fetal, donor1	10073-102A1	7.29	5.58	2.57	1.72	1.72	2.57	0.43	2.15	0.00	0.00
occipital pole, adult, pool1	10036-101E9	18.69	4.97	4.34	1.50	0.95	0.95	0.71	0.47	0.79	1.02
olfactory region, adult	10195-103E6	22.54	8.79	5.16	3.63	1.72	1.72	0.76	0.96	0.96	1.53
optic nerve, donor1	10277-104E7	74.04	8.00	6.00	4.00	4.00	4.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	25.40	10.94	3.65	3.53	2.05	1.25	1.37	0.34	0.91	1.03
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	14.01	3.98	4.53	3.30	1.10	0.14	0.14	0.14	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	13.88	4.74	3.22	4.40	1.69	1.35	0.34	0.51	0.51	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	15.59	7.28	3.47	2.19	2.19	1.04	0.92	0.23	0.35	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	23.22	16.17	7.06	4.41	2.94	3.53	2.65	2.06	0.88	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	44.85	21.49	14.02	10.28	6.54	0.93	1.87	0.93	2.80	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	5.51	11.03	3.39	5.73	2.12	0.42	2.12	0.85	0.42	0.21
ovary, adult, pool1	10020-101D2	21.84	20.61	23.85	10.57	7.16	4.80	6.64	3.23	1.92	0.96
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	12.65	2.93	7.88	4.58	2.02	0.73	0.73	0.00	0.00	0.18
pancreas, adult, donor1	10049-101G4	29.16	20.69	17.87	3.76	4.70	3.76	0.94	3.76	2.82	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	28.79	16.18	9.20	8.52	4.26	4.77	2.38	0.34	1.19	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	35.27	31.13	6.62	6.79	6.13	0.83	1.32	0.50	2.65	0.33
paracentral gyrus, adult, pool1	10035-101E8	24.44	7.60	3.75	2.20	1.83	1.10	1.01	1.10	0.27	2.01
parietal cortex, adult, donor10258	10373-105G4	22.75	3.67	3.67	2.94	0.73	0.73	0.73	0.73	0.73	0.73
parietal lobe - adult, donor10196	10171-103B9	24.45	4.70	4.70	1.88	1.88	0.00	0.94	0.94	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	19.38	10.55	5.13	4.56	2.57	2.00	1.43	0.29	1.71	2.85
parietal lobe, adult, pool1	10034-101E7	23.62	7.93	3.00	3.26	1.85	0.97	1.15	1.06	1.41	2.11
parietal lobe, fetal, donor1	10072-101I9	7.76	3.88	2.91	2.91	0.00	1.94	0.97	1.94	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	6.73	7.48	2.24	1.12	2.24	1.12	1.50	0.37	0.37	0.00
parotid gland, adult	10199-103F1	23.43	7.40	8.02	3.08	1.85	6.17	1.85	1.23	1.23	0.00
penis, adult	10200-103F2	34.38	17.72	8.06	3.76	3.76	5.37	5.91	2.69	0.54	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	1.86	4.28	1.12	1.30	0.74	1.67	0.56	0.37	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	19.81	5.68	5.10	2.48	2.04	0.44	0.44	0.29	0.58	0.44
pineal gland - adult, donor10196	10179-103C8	27.09	4.52	1.29	0.65	1.29	0.65	0.00	0.65	0.00	2.58
pineal gland, adult, donor10252	10160-103A7	43.82	17.17	4.74	2.96	0.59	1.78	0.00	0.59	1.78	6.51
pineal gland, adult, donor10258	10377-105G8	30.10	11.29	3.14	1.88	2.51	0.00	2.51	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	28.33	8.09	5.06	4.05	2.02	6.07	2.02	2.02	1.01	3.04
pituitary gland, adult, donor10252	10162-103A9	34.40	11.47	7.30	5.73	6.78	5.21	1.56	2.08	5.21	5.21
pituitary gland, adult, donor10258	10378-105G9	45.12	20.43	6.81	3.40	5.96	4.26	2.55	2.55	1.70	0.85
placenta, adult, pool1	10021-101D3	17.95	18.28	10.00	8.82	4.73	3.66	3.66	1.51	1.51	0.54
plasma cell leukemia cell line:ARH-77	10840-111E3	1.32	0.53	0.26	0.13	0.13	0.00	0.00	0.00	0.00	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	26.46	16.96	7.63	7.94	3.74	2.02	1.56	1.25	0.78	2.33
pons, adult, pool1	10033-101E6	26.42	9.90	4.22	2.67	2.24	1.12	1.46	1.20	1.64	1.89
postcentral gyrus, adult, pool1	10032-101E5	22.49	6.10	3.66	1.66	1.83	1.31	1.22	1.39	0.61	1.92
promyelocytes/myelocytes PMC, donor1	12132-128D8	179.86	14.64	4.18	2.09	2.09	0.00	0.00	0.00	2.09	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	71.60	0.00	0.00	0.00	0.00	0.00	5.51	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	35.21	11.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	59.72	11.22	8.45	4.52	2.91	0.87	1.17	0.44	0.73	0.15
prostate cancer cell line:PC-3	10439-106E7	57.54	22.87	10.16	7.26	3.63	1.09	2.54	1.45	1.63	2.00
prostate, adult, pool1	10022-101D4	30.74	16.05	7.71	4.99	3.90	5.53	3.26	2.72	1.18	1.09
putamen, adult, donor10196	10176-103C5	15.58	3.54	3.54	4.01	2.60	2.36	1.42	1.65	1.42	1.65
putamen, adult, donor10252	10152-102I8	45.10	21.57	7.84	7.84	3.92	3.92	0.00	3.92	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	13.11	1.09	1.09	1.09	1.09	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	24.89	7.97	2.42	1.69	1.21	1.21	0.48	0.72	0.72	0.72
putamen, newborn, donor10223	10365-105F5	9.00	14.99	3.75	1.50	1.50	0.00	0.75	1.50	1.50	0.75
rectal cancer cell line:TT1TKB	10469-106I1	23.57	13.38	9.31	3.20	2.91	0.00	0.87	0.29	1.45	0.58
rectum, fetal, donor1	10067-101I4	22.26	12.52	13.91	6.95	6.95	6.95	5.56	5.56	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	20.35	11.66	2.33	4.88	2.12	0.64	0.85	1.48	1.27	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	50.12	15.74	25.68	13.25	7.46	1.24	2.90	0.83	0.41	1.66
retina, adult, pool1	10030-101E3	49.60	13.92	8.95	4.37	5.07	4.67	1.69	2.19	1.29	5.07
retinoblastoma cell line:Y79	10475-106I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	38.36	76.97	7.99	7.87	4.79	9.34	16.11	4.06	2.09	2.34
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	17.72	7.59	3.66	3.94	2.25	1.69	1.97	0.56	0.00	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	31.83	10.61	9.85	5.30	3.03	6.06	3.79	1.52	0.00	0.00
salivary acinar cells, donor1	11771-123I7	22.82	10.36	4.53	1.78	1.13	1.62	0.97	0.97	0.65	0.32
salivary acinar cells, donor2	11772-123I8	16.66	6.61	3.86	2.75	1.65	1.51	0.83	0.28	0.41	0.28
salivary acinar cells, donor3	11773-123I9	7.94	9.27	2.65	3.97	0.66	1.99	1.32	0.66	0.66	0.00
salivary gland, adult, pool1	10093-102C3	33.17	13.73	8.58	1.72	0.00	3.43	1.14	4.58	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	36.25	11.04	12.14	4.05	2.28	1.18	1.77	1.52	0.25	2.02
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	40.09	9.99	11.99	6.23	1.88	1.41	1.65	0.94	0.47	1.41
seminal vesicle, adult	10201-103F3	40.74	13.76	5.82	3.17	6.35	2.65	1.59	2.12	0.53	2.65
serous adenocarcinoma cell line:JHOS-2	10639-108I9	20.41	13.60	2.43	3.16	2.67	1.21	1.21	0.49	2.43	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	28.18	36.24	9.81	8.81	3.27	4.53	2.26	2.01	3.52	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	41.14	60.21	15.05	10.04	6.02	6.02	6.02	1.00	1.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	17.19	3.90	4.30	2.42	0.81	0.81	0.40	0.13	0.13	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	15.92	9.51	4.31	3.43	1.99	1.44	0.99	0.55	0.99	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	9.16	7.87	2.06	1.68	1.55	0.26	0.65	0.39	0.39	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	68.10	6.38	4.26	3.55	1.42	8.51	2.13	11.35	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	55.65	12.83	12.11	3.36	2.04	8.52	5.28	6.12	0.60	0.36
skeletal muscle, fetal, donor1	10066-101I3	13.07	9.05	14.07	4.02	3.02	0.00	0.00	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	0.00	0.00	6.79	6.79	6.79	0.00	13.57	6.79	0.00	0.00
skin, fetal, donor1	10065-101I2	11.99	8.84	6.31	6.31	6.31	3.79	3.16	3.79	1.89	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	20.34	6.00	1.67	2.67	1.33	1.00	0.67	0.67	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	14.50	5.36	2.84	3.15	2.21	1.58	1.26	0.32	0.32	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	26.60	3.08	8.29	2.89	0.96	0.58	1.35	1.73	0.39	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	10.38	8.41	2.80	3.79	2.64	0.82	0.66	0.49	0.66	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	12.22	1.45	8.85	1.45	0.97	0.32	0.00	0.32	0.00	0.64
small cell lung carcinoma cell line:WA-hT	10562-108A4	12.20	2.40	0.65	0.00	0.65	1.74	0.44	0.22	1.31	0.65
small intestine, adult, pool1	10024-101D6	24.72	138.55	20.19	30.82	18.75	1.43	3.70	1.91	3.22	4.78
small intestine, fetal, donor1	10064-101I1	14.25	33.17	33.17	13.51	9.34	2.70	4.42	0.25	1.72	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	33.85	10.77	7.18	2.05	2.05	1.03	0.00	1.03	3.08	0.00
smooth muscle, adult, pool1	10048-101G3	32.82	9.56	13.70	3.10	2.84	5.17	2.84	2.07	0.52	1.29
somatostatinoma cell line:QGP-1	10781-110G7	33.23	12.87	6.16	5.36	2.95	2.95	0.80	1.07	2.41	0.00
spinal cord - adult, donor10196	10181-103D1	34.18	7.11	5.96	2.52	1.61	1.84	1.61	1.38	0.92	1.15
spinal cord, adult, donor10252	10159-103A6	41.40	26.02	12.22	5.52	5.52	2.76	1.58	2.76	1.97	5.91
spinal cord, adult, donor10258	10369-105F9	46.35	14.53	3.46	1.38	2.77	4.84	1.38	1.38	0.69	0.00
spinal cord, fetal, donor1	10056-101H2	23.17	6.10	12.81	5.49	1.83	6.71	4.27	2.44	0.61	1.83
spinal cord, newborn, donor10223	10359-105E8	27.55	25.26	9.18	3.67	2.30	4.59	3.21	3.21	2.76	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	24.34	14.49	4.48	5.82	3.88	3.58	1.94	1.79	0.60	0.45
spleen, adult, pool1	10025-101D7	43.39	15.20	6.50	8.37	4.41	0.77	1.98	0.77	0.22	1.32
spleen, fetal, pool1	10044-101F8	27.41	17.88	8.58	5.09	3.97	2.86	1.83	1.19	0.95	1.91
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	42.15	11.01	7.03	6.08	3.61	0.95	1.52	0.38	0.38	0.95
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	26.91	13.63	8.39	6.64	4.54	1.75	1.75	2.45	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	17.20	4.69	1.56	3.13	1.95	0.00	0.39	0.00	1.17	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	27.35	5.07	3.26	2.36	1.24	2.48	1.91	0.45	0.45	0.79
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	0.42	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	42.31	22.42	6.35	4.65	5.08	2.54	0.85	0.85	1.27	0.42
stomach, fetal, donor1	10062-101H8	34.18	2.14	12.82	6.41	2.14	2.14	4.27	1.07	2.14	3.20
submaxillary gland, adult	10202-103F4	35.89	7.98	5.13	1.14	1.71	2.28	0.57	1.71	0.00	1.71
substantia nigra - adult, donor10196	10178-103C7	162.82	0.00	0.00	54.27	0.00	0.00	0.00	0.00	0.00	162.82
substantia nigra, adult, donor10252	10158-103A5	40.29	18.28	9.55	7.89	7.06	4.98	4.15	1.66	1.04	2.70
substantia nigra, adult, donor10258	10371-105G2	34.14	10.86	3.10	1.55	0.00	1.03	1.03	0.52	0.00	2.07
substantia nigra, newborn, donor10223	10358-105E7	13.42	16.25	6.36	7.07	2.12	4.24	3.53	0.71	1.41	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	8.25	9.63	5.27	5.27	3.44	1.15	0.92	0.23	1.38	0.92
temporal lobe, adult, pool1	10031-101E4	22.72	6.87	2.88	1.70	1.86	1.44	0.68	1.36	0.68	0.85
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	8.55	4.27	2.85	2.14	0.00	1.42	0.71	1.42	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	7.03	3.08	1.32	0.44	0.00	1.32	0.88	2.64	0.88	0.00
tenocyte, donor1	11763-123H8	15.71	20.60	8.03	7.33	5.24	6.63	5.59	2.79	0.70	0.70
tenocyte, donor2	11765-123I1	22.89	9.54	13.35	7.25	3.05	5.72	3.05	3.05	0.38	0.76
tenocyte, donor3	11768-123I4	18.16	35.21	11.12	7.78	5.19	7.41	6.67	3.34	2.22	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	17.51	5.27	5.95	3.23	2.38	0.17	0.34	0.17	0.17	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	8.02	1.85	1.08	0.46	0.31	0.31	0.15	0.15	0.15	0.00
teratocarcinoma cell line:PA-1	10807-111A6	15.34	3.10	4.49	2.17	1.86	0.00	0.15	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	6.22	5.59	7.36	3.05	1.52	0.63	0.00	0.00	0.51	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	3.40	1.51	1.89	0.76	0.00	0.00	0.00	0.00	0.38	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	2.73	9.60	8.83	3.93	1.31	0.22	0.00	0.22	0.44	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	15.96	14.33	10.42	1.95	0.33	0.33	0.00	0.33	1.63	0.33
testis, adult, pool1	10026-101D8	63.99	11.49	10.84	4.83	3.87	4.19	1.93	2.15	0.86	2.47
testis, adult, pool2	10096-102C6	86.16	13.08	6.32	5.41	3.16	3.16	2.71	2.71	0.00	5.86
thalamus - adult, donor10196	10168-103B6	48.58	7.73	3.31	3.31	1.10	4.42	1.10	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	38.76	15.78	9.22	5.47	4.22	4.69	2.34	1.41	2.03	5.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	46.19	9.24	1.54	0.00	0.00	3.08	0.00	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	23.55	5.11	3.95	2.64	1.15	2.47	1.81	1.81	0.49	0.33
thalamus, newborn, donor10223	10366-105F6	9.21	6.90	1.73	1.15	0.00	1.73	0.00	0.00	0.58	0.00
throat, adult	10209-103G2	39.70	22.97	4.99	4.99	2.50	6.74	1.50	3.50	2.50	1.75
throat, fetal, donor1	10061-101H7	22.55	3.96	9.14	2.74	3.96	3.35	1.83	1.22	0.91	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	0.20	2.38	0.79	1.99	0.60	0.99	0.40	0.00	0.20	0.00
thymus, adult, pool1	10027-101D9	6.96	2.39	1.69	0.40	0.80	0.50	0.30	0.40	0.10	0.10
thymus, fetal, pool1	10043-101F7	11.12	6.34	1.77	1.66	1.77	0.83	0.31	0.10	0.62	1.04
thyroid carcinoma cell line:KHM-5M	10776-110G2	42.41	24.20	8.64	12.23	4.79	2.79	1.86	0.53	1.73	0.13
thyroid carcinoma cell line:TCO-1	10783-110G9	42.05	10.90	12.43	8.24	4.75	2.79	1.40	1.40	0.84	1.12
thyroid, adult, pool1	10028-101E1	41.62	18.66	5.51	5.13	4.29	4.01	2.24	1.40	2.43	0.93
thyroid, fetal, donor1	10060-101H6	33.49	13.71	8.70	3.69	2.90	2.64	1.85	0.79	1.58	0.53
tongue epidermis (fungiform papillae), donor1	10288-104F9	49.27	9.24	3.08	6.16	3.08	6.16	6.16	3.08	0.00	0.00
tongue, adult	10203-103F5	30.00	11.40	8.37	5.58	1.63	6.05	1.86	2.33	0.23	0.93
tongue, fetal, donor1	10059-101H5	20.49	11.43	7.88	4.73	2.76	5.91	2.36	4.34	0.00	0.00
tonsil, adult, pool1	10047-101G2	28.85	15.53	4.21	5.31	3.71	2.80	1.50	1.30	1.10	2.10
trachea, adult, pool1	10029-101E2	25.11	18.65	8.18	5.64	2.94	5.64	4.74	2.13	1.47	0.98
trachea, fetal, donor1	10058-101H4	13.08	10.00	6.92	4.62	1.92	3.85	3.08	1.54	1.15	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	23.38	14.17	4.96	3.54	2.13	4.25	3.19	0.71	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	9.02	4.86	2.63	2.74	0.71	0.91	0.91	0.51	0.41	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	59.38	14.10	14.26	5.17	3.45	1.25	0.47	0.47	0.31	1.10
tridermal teratoma cell line:HGRT	10694-109G1	20.93	5.71	3.81	0.00	3.81	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	15.24	11.00	5.76	2.37	3.39	0.68	0.59	0.51	0.42	0.59
umbilical cord, fetal, donor1	10057-101H3	25.04	14.61	10.43	6.26	4.17	10.43	0.00	0.00	0.00	2.09
uterus, adult, pool1	10100-102D1	27.64	20.82	15.02	6.65	3.58	7.85	2.73	3.41	1.54	1.19
uterus, fetal, donor1	10055-101H1	26.11	19.97	10.24	3.58	3.58	3.58	3.58	1.54	1.54	1.02
vagina, adult	10204-103F6	10.99	13.57	14.86	1.94	3.23	1.29	1.29	1.29	1.29	0.00
vein, adult	10191-103E2	25.87	12.71	9.64	2.41	3.73	3.73	1.32	1.75	1.10	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00